≡

View the Patent Register

With effect from 1 March 2012, the Intellectual Property Office took over responsibility for the registration and administration of patents from the Greffe and the Royal Court.

The table below details the patents that have been registered in the Bailiwick of Guernsey and their current status.

Register Search -

If you wish to search for a specific Patent or Proprietor please press 'Ctrl F' in order to search this web page.

More detailed information regarding the original application and any subsequent administration can be found by requesting a Statement of the Register. This can be obtained by emailing enquiries@guernseyregistry.com, attaching a pdf icon Request for copy documents [471kb] form and details of payment (£25 - uncertified copy, £50 - certified copy).

Alternatively, further information regarding the overseas reference is available from the register of the United Kingdom Intellectual Property Office.

Should you require any further information please contact the Registry. Our office opening hours and contact details can be found through the 'contact' section of our website here: http://www.guernseyregistry.com/contact

Last updated: 25/03/2024


Guernsey Reference	Patent Title	Proprietor Name	Overseas Jurisdiction	Overseas Reference	Patent Status
GG-GP706	METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS	MERCK SHARP & DOHME LLC	The European Patent Office	EP3413897	Current
GG-GP705	Purification of recombinantly produced polypeptides	1) MEDIMMUNE LIMITED and 2) MEDIMMUNE, LLC	The European Patent Office	EP2997036	Current
GG-GP704	Stable anti-IFNAR1 formulation	AstraZeneca AB	The European Patent Office	EP3769781	Current
GG-GP703	Combination of EGFR inhibitor and MEK inhibitor for use in the treatment of NRAS mutated cancer	ASTRAZENECA AB	The European Patent Office	EP3125885	Current
GG-GP702	Tgf-beta receptor type ii fusion proteins and uses thereof	ACCELERON PHARMA INC.	The European Patent Office	EP3628049	Current
GG-GP701	Lipopeptide compositions and related methods	CUBIST PHARMACEUTICALS LLC	The European Patent Office	EP2504353 B2	Current
GG-GP700	Applicator for inserting an implant	Merck Sharp & Dohme B.V.	The European Patent Office	EP3417905 b2	Current
GG-GP699	Use of c-Met inhibitors to treat cancers harbouring MET mutations	AstraZeneca AB	The European Patent Office	EP3515418	Current
GG-GP698	NEW BICYCLIC DIHYDROQUINOLINE-2-ONE DERIVATIVES	F. Hoffmann-La Roche AG	The European Patent Office	EP2758388	Current
GG-GP697	Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator	VERTEX PHARMACEUTICALS INCORPORATED	The European Patent Office	EP3551622	Current
GG-GP696	Pharmaceutical compositions comprising AZD9291	ASTRAZENECA AB	The European Patent Office	EP3089741	Current
GG-GP695	Compounds and conjugates thereof	MedImmune Limited	The European Patent Office	EP3946464	Current
GG-GP694	Modulators of cystic fibrosis transmembrane conductance regulator	Vertex Pharmaceuticals Incorporated	The European Patent Office	EP3203840	Current
GG-GP693	Diacylglycerol acyltransferase 2 inhibitors	PFIZER INC.	The European Patent Office	EP3500564	Current
GG-GP692	Certain triazolopyrazines, compositions thereof and methods of use therefor	Hutchison Medipharma Limited	The European Patent Office	EP3795573	Current
GG-GP691	Compositions and methods for modulating ttr expression	IONIS PHARMACEUTICALS, INC.	The European Patent Office	EP3524680	Current
GG-GP690	Anti-her3 antibody-drug conjugate	AIICHI SANKYO COMPANY, LIMITED & DAIICHI SANKYO EUROPE GMBH	The European Patent Office	EP3129063	Current
GG-GP689	Halo-substituted piperidines as orexin receptor modulators	ASTRAZENECA AB & EOLAS THERAPEUTICS INC.	The European Patent Office	EP3414241	Current
GG-GP688	A novel il33 form, mutated forms of il33, antibodies, assays and methods of using the same	MEDIMMUNE LIMITED	The European Patent Office	EP3277717	Current
GG-GP687	Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and "azd9291 aniline" or a salt thereof	ASTRAZENECA AB	The European Patent Office	EP3411038	Current
GG-GP686	Anti-lag3 antibodies and antigen-binding fragments	Merck Sharp & Dohme LLC	The European Patent Office	EP3182999	Current
GG-GP685	In silico design of mammalian promoters with user-defined functionality	MEDIMMUNE LIMITED	The European Patent Office	EP3612628	Current
GG-GP684	N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitors	Redx Pharma PLC	The European Patent Office	EP3204381	Current
GG-GP683	Synthetic intermediate useful in the preparation of triazolopyridine c-met inhibitors	Hutchison Medipharma Limited	The European Patent Office	EP3511330	Current
GG-GP682	Processes for preparing (1-(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)	Incyte Corporation	The European Patent Office	EP3746429	Current
GG-GP681	Glucagon and glp-1 co-agonists for the treatment of obesity	MEDIMMUNE LIMITED	The European Patent Office	EP3495380	Current
GG-GP680	Embedded multiple-part sensor within a plunger rod to capture and transmit injection information	MedImmune, LLC	The European Patent Office	EP3554587	Current
GG-GP679	2-(2,4,5-substituted-anilino)pyrimidine compounds	AstraZeneca AB	The European Patent Office	EP3686193	Current
GG-GP678	Antibodies against cd38 for treatment of multiple myeloma	GENMAB A/S	The European Patent Office	EP2567976	Current
GG-GP677	Systems and methods for generating and maintaining immutable digital meeting records within distributed network nodes.	NORTHERN TRUST CORPORATION	The European Patent Office	EP3729287	Current
GG-GP676	Sustained release formulations using non-aqueous carriers	Amylin Pharmaceuticals, LLC & AstraZeneca Pharmaceuticals LP	The European Patent Office	EP2341905	Current
GG-GP675	Systems and methods for generating, uploading, and executing codes blocks within distributed network nodes	NORTHERN TRUST CORPORATION	The European Patent Office	EP3896894	Current
GG-GP674	RSV-specific antibodies and functional parts thereof	MedImmune Limited	The European Patent Office	EP3094353	Current
GG-GP673	Polycyclic amide derivatives as CDK9 inhibitors	AstraZeneca AB	The European Patent Office	EP3539961	Current
GG-GP672	Methods for improving asthma symptoms using benralizumab	AstraZeneca AB	The European Patent Office	EP3536339	Current
GG-GP671	Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide	Acerta Pharma B.V.	The European Patent Office	EP3613745	Current
GG-GP670	8-[6-[3-(amino)propoxy]-3-pyridyl]-1-isopropyl-imidazo[4,5-c]quinolin-2-one derivatives as selective modulators of ataxia telangiectasia mutated (ATM) kinase	AstraZeneca AB	The European Patent Office	EP3350180	Current
GG-GP669	Antibodies to alpha-synuclein and uses thereof	MedImmune Limited	The European Patent Office	EP3463435	Current
GG-GP668	Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto	Modernatx, Inc.	The European Patent Office	EP3464338	Current
GG-GP667	Improved alpha-v beta-8 antibodies	MedImmune Limited	The European Patent Office	EP3157561	Current
GG-GP666	Stable, aqueous antibody formulations	AstraZeneca AB	The European Patent Office	EP3060229	Current
GG-GP665	Therapeutic combinations of a BTK inhibitor, a PD-1 inhibitor and/or a PD-L1 inhibitor	Acerta Pharma B.V.	The European Patent Office	EP3179992	Current
GG-GP664	4'-substituted nucleoside-derivatives as HIV reverse transcriptase inhibitors	Merck Sharp & Dohme Corp.	The European Patent Office	EP3122752	Current
GG-GP663	ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF	Compugen Ltd.	The European Patent Office	EP3347379B1	Current
GG-GP662	Amino-triazolopyridine compounds and their use in treating cancer	AstraZeneca AB	The European Patent Office	EP3558997	Current
GG-GP661	Hand strap for a plastic bag	Papier-Mettler KG	The European Patent Office	EP3770078	Current
GG-GP660	Benzo[b]thiophene compounds as sting agonists	MERCK SHARP & DOHME CORP.	The European Patent Office	EP3523287	Current
GG-GP659	Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof	ArQule, Inc.	The European Patent Office	EP3394065	Current
GG-GP658	Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors	Pfizer Inc.	The European Patent Office	EP3126330	Current
GG-GP657	Substituted dihydroisoquinolinone compounds	Pfizer Inc.	The European Patent Office	EP3157915	Current
GG-GP656	Binding molecules specific for cd73 and uses thereof	MEDIMMUNE LIMITED	The European Patent Office	EP3218406	Current
GG-GP655	Card game interface	Marcus A.Katz	European (UK)	EP3593872B1	Current
GG-GP654	A conditional replicating cytomegalovirus as a vaccine for CMV	Merck Sharp & Dohme Corp.	The European Patent Office	EP3251700	Current
GG-GP653	Neutralization of inhibitory pathways in lymphocytes	Innate Pharma	The European Patent Office	EP3405495	Current
GG-GP652	Therapeutic combinations of a BTK inhibitor and a BCL-2 inhibitor	Acerta Pharma B.V.	The European Patent Office	EP3179991	Current
GG-GP651	Heated inflatable exercise chamber with gas-permeable inner membrane	Hotpod Holdings Ltd.	United States of America	9708830B2	Current
GG-GP650	4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as BTK-inhibitors	Merck Sharp & Dohme B.V.	The European Patent Office	EP3689878	Current
GG-GP649	A crystal comprising an L-malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-owo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide for use as a medicament	Pharmacia & Upjohn Company LLC	The European Patent Office	EP3168218	Current
GG-GP648	Anti-CD19 antibody formulations	MorphoSys AG	The European Patent Office	EP3475303	Current
GG-GP647	Salts of PI3K inhibitor and processes for their preparation	Incyte Corporation	The European Patent Office	EP3262046	Current
GG-GP646	Bipyrazole salt as JAK inhibitor	Incyte Corporation	The European Patent Office	EP3231801	Current
GG-GP645	Neutralizing anti-influenza A antibodies and uses thereof	Medlmmune, LLC and Hunabs Biomed S.A.	The European Patent Office	EP3052192	Current
GG-GP644	Protease-resistant lipidated GLP-1 analogs	Medlmmune Limited	The European Patent Office	EP3307769	Current
GG-GP643	Plastic bag and hand strap for a plastic bag	Papier-Mettler KG	The European Patent Office	EP3450343	Current
GG-GP642	4-Imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk-inhibitors	Merck Sharp & Dohme B.V.	The European Patent Office	EP2734522	Current
GG-GP641	Compositions and methods for synthesizing 5'-Capped RNAs	TriLink BioTechnologies, LLC	The European Patent Office	EP3352584	Current
GG-GP640	Methods for increasing forced expiratory volume in asthmatics using benralizumab	AstraZeneca AB	The European Patent Office	EP3520811	Current
GG-GP639	Pharmaceutical compositions for the treatment of CFTR mediated diseases	Vertex Pharmaceuticals Incorporated	The European Patent Office	EP2914248	Current
GG-GP638	Anti-CTLA-4 antibody compositions	Pfizer Products Inc.	The European Patent Office	EP2620450	Current
GG-GP637	ANTIBODIES TO AMYLOID BETA	Medimmune Limited	The European Patent Office	EP2906597	Current
GG-GP636	Anti-trop2 antibody-drug conjugate	Daiichi Sankyo Company & Sapporo Medical University	The European Patent Office	EP3088419	Current
GG-GP635	NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES	Innate Pharma	The European Patent Office	EP3193931	Current
GG-GP634	Use of zirconium silicate for the treatment of hyperkalemia	ZS Pharma, Inc	The European Patent Office	EP2673237	Current
GG-GP633	Immediate release tablet formulations	1) Astrazeneca AB 2) AstraZeneca UK Limited	The European Patent Office	EP2498759	Current
GG-GP632	Methods of producing immunoconjugates	Medlmmune, LLC	The European Patent Office	EP2934597	Current
GG-GP631	2-(2,4,5-substituted-anilino)pyrimidine derivatives as EGFR modulators useful for treating cancer	AstraZeneca AB	The European Patent Office	EP3333161	Current
GG-GP630	Sustained release dosage forms for a JAK1 inhibitor	Incyte Corporation	The European Patent Office	EP3030227	Current
GG-GP629	Compositions and methods for inhibiting arginase activity	Calithera Biosciences, Inc.	The European Patent Office	EP3559009	Current
GG-GP628	Purified active polypeptides or immunoconjugates	Medlmmune, LLC	The European Patent Office	EP3434346	Current
GG-GP627	1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins	Incyte Corporation	The European Patent Office	EP3134403	Current
GG-GP626	Binding molecules specific for ASCT2 and uses thereof	Medlmmune LLC	The European Patent Office	EP3374398	Current
GG-GP625	Applicator for inserting an implant	Merck Sharp & Dohme B.V.	The European Patent Office	EP3417905	Current
GG-GP624	Stable anti-IFNAR1 formulation	AstraZeneca AB	The European Patent Office	EP3337502	Current
GG-GP623	Aryl ethers and uses thereof	Peloton Therapeutics, Inc.	The European Patent Office	EP3417851	Current
GG-GP622	Method for purifying immunoconjugates	MedImmune, LLC	The European Patent Office	EP2613857	Current
GG-GP621	C-3 and C-17 modified triterpenoids as HIV-1 inhibitors	ViiV Healthcare UK (No. 5) Limited	The European Patent Office	EP3411381	Current
GG-GP620	Aminopyrimidinyl compounds as jak inhibitors	Pfizer Inc	The European Patent Office	EP3183247 B9	Current
GG-GP619	Modified polypeptides for bispecific antibody scaffolds	MedImmune, LLC	The European Patent Office	EP2794905	Current
GG-GP618	Exendin for treating diabetes and reducing body weight	1) Amylin Pharmaceuticals, LLC 2) AstraZeneca Pharmaceuticals LP	The European Patent Office	EP2347762	Current
GG-GP617	4-amino-2-(1H-pyrazolo[3,4-b]pyridin-3-yl)-6-oxo-6,7-di hydro-5H-pyrrolo[2,3-D]pyrimidine derivatives and the respective (1H-indazol-3-yl) derivatives as cGMP modulators for treating cardiovascular diseases	Merck Sharp & Dohme Corp.	The European Patent Office	EP3394067	Current
GG-GP616	Use of pyrazolopyrimidine derivatives for the treatment of PI3K related disorders	Incyte Holdings Corporation	The European Patent Office	EP2961410	Current
GG-GP615	Chimeric protein composed of ngf antagonist domain and a tnfa antagonist domain	MedImmune Limited	The European Patent Office	EP3099713	Current
GG-GP614	Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators	Forma Therapeutics, Inc.	The European Patent Office	EP3448859	Current
GG-GP613	Triterpenoids with HIV maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent	ViiV Healthcare UK (No.4) Limited	The European Patent Office	EP3129392	Current
GG-GP612	Macrocyclic mcl1 inhibitors for treating cancer	AstraZeneca AB	The European Patent Office	EP3445767	Current
GG-GP611	(2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase i inhibitors	AstraZeneca AB	The European Patent Office	EP3097086	Current
GG-GP610	Optically active 2-aryl cyclopropane carboxamide intermediate	AstraZeneca AB	The European Patent Office	EP2644591	Current
GG-GP609	Therapeutic polymeric nanoparticles and methods of making and using same	AstraZeneca AB	The European Patent Office	EP3311845	Current
GG-GP608	Aminopyrimidinyl compounds as jak inhibitors	Pfizer Inc.	The European Patent Office	EP3183247	Current
GG-GP607	Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides	Pfizer Inc.	The European Patent Office	EP3077395	Current
GG-GP606	Compositions, methods & systems for respiratory delivery of two or more active agents	Pearl Therapeutics, Inc	The European Patent Office	EP3111926	Current
GG-GP605	Compositions for respiratory delivery of active agents and associated methods and systems	Pearl Therapeutics, Inc.	The European Patent Office	EP3111927	Current
GG-GP604	CTLA-4 variants	MedImmune Limited	The European Patent Office	EP3207938	Current
GG-GP603	Anti-HER2 antibody-drug conjugate	Daiichi Sankyo Company, Limited	The European Patent Office	EP3101032	Current
GG-GP602	Antibody-drug conjugate	Daiichi Sankyo Company, Limited	The European Patent Office	EP2907824	Current
GG-GP601	Methods and compositions for sustained delivery of drugs	Intratus, Inc.	The European Patent Office	EP2493474	Current
GG-GP600	Delivery of cholesteryl ester to steroidogenic tissues	Alphacore Pharma LLC	The European Patent Office	EP2566505	Current
GG-GP599	Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems	Pearl Therapeutics, Inc.	The European Patent Office	EP3106149	Current
GG-GP598	1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases	AstraZeneca AB	The European Patent Office	EP3174881	Current
GG-GP597	Compositions and methods for inhibiting arginase activity	Calithera Biosciences, Inc.	The European Patent Office	EP3368541	Current
GG-GP596	Thioacetate compounds, compositions and methods of use	Ardea Biosciences, Inc.	The European Patent Office	EP2585437	Current
GG-GP595	Thioacetate compounds, compositions and methods of use	Ardea Biosciences, Inc.	The European Patent Office	EP2712861	Current
GG-GP594	Thioacetate compounds, compositions and methods of use	Ardea Biosciences, Inc.	The European Patent Office	EP2975025	Current
GG-GP593	Antibodies binding beta klotho domain 2 and methods of use thereof	NGM BIOPHARMACEUTICALS, INC.	The European Patent Office	EP3097122	Current
GG-GP592	Cementitious binders, activators and methods for making concrete	DB Group (Holdings) Limited	The European Patent Office	EP2855394	Current
GG-GP591	Activator composition and method for making concrete	DB Group (Holdings) Limited	United Kingdom	2525705	Current
GG-GP590	Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo [1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide	Acerta Pharma B.V.	The European Patent Office	EP3317281	Current
GG-GP589	Estrogen receptor modulators	AstraZeneca AB	The European Patent Office	EP3494116	Current
GG-GP588	Systems and methods for digital identity management and permission controls within distributed network nodes	Northern Trust Corporation	The European Patent Office	EP3458982	Current
GG-GP587	Anti-B7-H1 antibodies for treating tumors	MedImmune Limited	The European Patent Office	EP3043816	Current
GG-GP586	Antibodies directed to alphaVbeta6 and uses thereof	MedImmune Limited	The European Patent Office	EP2064244	Current
GG-GP585	Pyrazole derivatives useful as 5-lipoxygenase activating protein (flap) inhibitors	AstraZeneca AB	The European Patent Office	EP3292105	Current
GG-GP584	1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase	AstraZeneca AB	The European Patent Office	EP3227294	Current
GG-GP583	ANTIBODIES THAT SPECIFICALLY BIND STAPHYLOCOCCUS AUREUS ALPHA TOXIN AND METHODS OF USE	MedImmune LLC	The European Patent Office	EP2673373	Current
GG-GP582	TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA	1) PIERIS PHARMACEUTICALS GMBH 2 2) ASTRAZENECA AB	The European Patent Office	EP2580236	Current
GG-GP581	Anti-nkg2a antibodies and uses thereof	Novo Nordisk A/S	The European Patent Office	EP2426150	Current
GG-GP580	Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer	MedImmune Limited	The European Patent Office	EP3142751	Current
GG-GP579	6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivative useful in the treatment of cancer	AstraZeneca AB	The European Patent Office	EP3433256	Current
GG-GP578	Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus kinases (JAK)	Pfizer Inc.	The European Patent Office	EP2958921	Current
GG-GP577	Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)	Medivation Technologies LLC	The European Patent Office	EP2767537	Current
GG-GP576	Treatment regimens using anti-nkg2a antibodies	Innate Pharma	The European Patent Office	EP3193929	Current
GG-GP575	Refrigerator-temperature stable influenza vaccine compositions	MedImmune, LLC	The European Patent Office	EP2769735	Current
GG-GP574	Targeted binding agents against B7-H1	Medlmmune Limited	The European Patent Office	EP3279215	Current
GG-GP573	Methods for improving asthma symptoms using benralizumab	AstraZeneca AB	The European Patent Office	EP3033103	Current
GG-GP572	Novel fused pyridine compounds as casein kinase inhibitors	Pfizer Inc	The European Patent Office	EP2654750	Current
GG-GP571	Bipyrazole derivatives as JAK inhibitors	Incyte Corporation	The European Patent Office	EP2997023	Current
GG-GP570	Methods for increasing forced expiratory volume in asthmatics using benralizumab	AstraZeneca AB	The European Patent Office	EP 3033104	Current
GG-GP569	Macrocyclic derivatives for the treatment of proliferative diseases	Pfizer Inc.	The European Patent Office	EP 2822953	Current
GG-GP568	Polycyclic amide derivatives as CDK9 inhibitors	AstraZeneca AB	The European Patent Office	EP 3313838	Current
GG-GP567	Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use	MedImmune LLC	The European Patent Office	EP 2673373	Current
GG-GP566	5-phenoxy-3H-pyrimidin-4-one derivatives and their uses as HIV reverse transcriptase inhibitors	Merck Sharp & Dohme Corp	The European Patent Office	EP 2903977	Current
GG-GP565	Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl	Array BioPharma, Inc.	The European Patent Office	EP 2712358	Current
GG-GP564	Heterocyclylamines as Pl3K inhibitors	Incyte Holdings Corporation	The European Patent Office	EP 2751109	Current
GG-GP563	Tiled pitched roofs	Modugroup Limited	The European Patent Office	EP 2923007	Current
GG-GP562	Substituted tricyclic compounds as FGFR inhibitors	Incyte Holdings Corporation	The European Patent Office	EP2861595	Current
GG-GP561	Benzimidazole derivatives	Pfizer Inc.	The European Patent Office	EP2170860	Current
GG-GP560	Novel selective androgen receptor modulators	Pfizer Inc.	The European Patent Office	EP2925725	Current
GG-GP559	New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds	NuCana plc	The European Patent Office	EP3224268	Current
GG-GP558	Methods for reducing exacerbation rates of asthma using benralizumab	AstraZeneca AB	The European Patent Office	EP3033101	Current
GG-GP557	N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors	Pfizer Inc.	The European Patent Office	EP2621493	Current
GG-GP556	Calicheamicin derivative-carrier conjugates	Wyeth Holdings LLC	The European Patent Office	EP1507556	Current
GG-GP555	Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta 2 adrenergic receptor agonists and associated methods and systems	Pearl Therapeutics, Inc.	The European Patent Office	EP2435023	Current
GG-GP554	Compositions for respiratory delivery of active agents and associated methods and systems	Pearl Therapeutics, Inc.	The European Patent Office	EP2435024	Current
GG-GP553	Respiratory delivery of active agents	Pearl Therapeutics, Inc.	The European Patent Office	EP2435025	Current
GG-GP552	Modulation of signal transducer and activator of transcription 3 (stat3) expression	Ionis Pharmaceuticals, Inc.	The European Patent Office	EP2697243	Current
GG-GP551	CARD GAME INTERFACE	Marcus A. Katz	The European Patent Office	EP2352563	Current
GG-GP550	Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia	MedImmune Limited	The European Patent Office	EP3041490	Current
GG-GP549	Topical formulation for a JAK inhibitor	Incyte Holdings Corporation	The European Patent Office	EP2574168	Current
GG-GP548	Benzoxazinone amides as mineralocorticoid receptor modulators	AstraZeneca AB	The European Patent Office	EP3160948	Current
GG-GP547	Glucagon/GLP-1 agonists for the treatment of obesity	MedImmune Limited	The European Patent Office	EP2931745	Current
GG-GP546	Lipopeptide compositions and related methods	Cubist Pharmaceuticals LLC	The European Patent Office	EP2504353	Current
GG-GP545	Piperidin-4-yl azetidine derivatives as JAK1 inhibitors	Incyte Holdings Corporation	The European Patent Office	EP3050882	Current
GG-GP544	Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer	AstraZeneca AB	The European Patent Office	EP3140303	Current
GG-GP543	1,3,4-thiadiazole compounds and their use in treating cancer	AstraZeneca AB and Cancer Research Technology Limited	The European Patent Office	EP314894	Current
GG-GP542	Piperidin-4-yl azetidine derivatives as JAK1 inhibitors	Incyte Holdings Corporation	The European Patent Office	EP2545045	Current
GG-GP541	Processes and intermediates for making a JAK inhibitor	Incyte Holdings Corporation	The European Patent Office	EP2753621	Current
GG-GP540	Antiviral therapy	ViiV Healthcare Company	The European Patent Office	EP3127542	Current
GG-GP539	Antiviral therapy	ViiV Healthcare Company	The European Patent Office	EP2932970	Current
GG-GP538	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives	ViiV Healthcare UK (No. 4) Limited	The European Patent Office	EP2801576	Current
GG-GP537	Novel FXR (NR1H4) modulating compounds	Gilead Sciences, Inc.	The European Patent Office	EP2731676	Current
GG-GP536	High purity lipopeptides, lipopeptide micelles and processes for preparing same	Cubist Pharmaceuticals, LLC	The European Patent Office	EP2264047	Current
GG-GP535	Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments	Merck Sharp & Dohme Corp.	The European Patent Office	EP2691112	Current
GG-GP534	Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds suitable for treatment or prevention of central nervous system disorders	Merck Sharp & Dohme Corp.	The European Patent Office	EP2945632	Current
GG-GP533	Determining a common secret for the secure exchange of information and hierarchical, deterministic cryptographic keys	Nchain Holdings Limited	The European Patent Office	EP3268914	Current
GG-GP532	Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus Kinase inhibitors	Incyte Holdings Corporation	The European Patent Office	EP2348023	Current
GG-GP531	Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus Kinase inhibitors	Incyte Holdings Corporation	The European Patent Office	EP2343299	Current
GG-GP530	DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form	Omthera Pharmaceuticals Inc. & Chysalis Pharma AG	The European Patent Office	EP2800563	Current
GG-GP529	N-acylsulfonamide apoptosis promoters	AstraZeneca AB	The European Patent Office	EP2601177	Current
GG-GP528	Novel RIG-I ligands and methods for producing them	Rheinische Friedrich-Wilhelms-Universität Bonn	The European Patent Office	EP2903997	Current
GG-GP527	Method and System for Single Sign on with Dynamic Authentication Levels	HSBC Technology & Services (USA) Inc.	The European Patent Office	EP2304616	Current
GG-GP526	Calicheamicin derivative-carrier conjugates	Wyeth Holdings LLC	The European Patent Office	EP2371392	Current
GG-GP525	2-(2, 4, 5-substituted-anilino) pyrimidine derivatives as EGFR modulators useful for treating cancer	AstraZeneca AB	The European Patent Office	EP3009431	Current
GG-GP524	Diarylhydantoin compound	The Regents of the University	The European Patent Office	EP1893196	Current
GG-GP523	Chemical compounds	NuCana plc	The European Patent Office	EP2955190	Current
GG-GP522	A conditional replicating cytomegalovirus as a vaccine for CMV	Merck Sharp & Dohme Corp	The European Patent Office	EP2753364	Current
GG-GP521	Biocidal boronophthalide compounds	Anacor Pharmaceuticals, Inc.	The European Patent Office	EP2343304	Current
GG-GP520	Methods for enhanced production of bone morphogenetic proteins	Wyeth LLC	The European Patent Office	EP2310523	Current
GG-GP519	Formulation comprising a gemcitabine-prodrug	NuCana plc	The European Patent Office	EP3119794	Current
GG-GP518	Targeted binding agents against B7-H1	MedImmune Limited	The European Patent Office	EP25044364	Current
GG-GP517	Therapeutic polymeric nanoparticles and methods of making and using same	AstraZeneca AB	The European Patent Office	EP3046584	Current
GG-GP516	Injection device and method of assembly and activation	Hospira, Inc.	The European Patent Office	EP2021050	Current
GG-GP515	Processes for the convergent synthesis of calicheamicin derivatives	Wyeth LLC	The European Patent Office	EP1987048	Current
GG-GP514	Anti-beta-amyloid antibody and uses thereof	University of Zurich	The European Patent Office	EP2436696	Current
GG-GP513	Modulators of ATP-Binding Cassette transporters	Vertex Pharmaceuticals Incorporated	The European Patent Office	EP2365972	Current
GG-GP512	Key and disc tumbler cylinder lock	Abloy Oy	The European Patent Office	EP2815045	Current
GG-GP511	2-methylmorpholine pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors	KuDOS Pharmaceuticals Limited	The European Patent Office	EP2057156	Current
GG-GP510	Lipidated immune response modifier compound compositions, formulations, and methods	3M Innovative Properties Company	European (UK)	EP2606047	Current
GG-GP509	Glucagon/GLP-1 receptor co-agonists	Indiana University Research & Technology Corporation	United Kingdom	EP2723367	Current
GG-GP508	Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof	Pfizer Inc.	The European Patent Office	EP2445883	Current
GG-GP507	Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors	Pfizer Products Inc.	European (UK)	EP1869019	Current
GG-GP506	1,2,4-triazine-4-amine derivatives	Heptares Therapeutics Limited	European (UK)	EP2531492	Current
GG-GP505	5-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl carboxamides as JAK inhibitors	Galapagos N.V	European (UK)	EP2445911	Current
GG-GP504	Pharmaceutical formulation 514	AstraZeneca UK Limited	European (UK)	EP2346495	Current
GG-GP503	Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids	Warner-Lambert Company LLC	European (UK)	EP1301472	Current
GG-GP502	Antiviral compounds	Gilead Pharmasset LLC	European (UK)	EP2430014	Current
GG-GP501	Inhibitors of hepatitis C virus	Gilead Sciences, Inc.	European (UK)	EP2870160	Current
GG-GP500	Condensed imidazolylimidazoles as antiviralcompounds	Gilead Pharmasset LLC	European (UK)	EP2635588	Current
GG-GP499	Compounds and their use as BACE inhibitors	AstraZeneca AB	European (UK)	EP2655378	Current
GG-GP498	Aminoheteroaryl compounds as protein kinaseinhibitors	Sugen, Inc.	European (UK)	EP2476667	Current
GG-GP497	Heterocyclic modulators of ATP-binding cassette transporters	Vertex Pharmaceuticals Incorporated	European (UK)	EP2774925	Current
GG-GP496	Apoptosis signal-regulating kinase inhibitor	Gilead Sciences, Inc.	European (UK)	EP2807151	Current
GG-GP495	Automatic injector	Meridian Medical Technologies, Inc.	European (UK)	EP2311510	Current
GG-GP494	A method for fitting a bra	MARKS AND SPENCER PLC	United Kingdom	EP2997841	Current
GG-GP493	Dihydropyrazolopyrimidinone derivative	MSD K.K.	United Kingdom	EP2017278	Current
GG-GP492	Benzodioxinyl substituted indazole derivatives	Astrazeneca AB & Bayer Pharma Aktiengesellschaft	United Kingdom	EP2291369	Current
GG-GP491	Modulators of atp-binding cassette transporters	VERTEX PHARMACEUTICALS INCORPORATED	United Kingdom	EP2771345	Current
GG-GP490	Fused bicyclic oxazolidinone cetp inhibitor	MERCK SHARP & DOHME CORP.	United Kingdom	EP2771345	Current
GG-GP489	Bicycloaniline derivative	MSD K.K.	United Kingdom	EP2168966	Current
GG-GP488	Heterobifunctional pan-selectin inhibitors	GlycoMimetics, Inc.	United Kingdom	EP1934236	Current
GG-GP487	DRIVER PROFILING SYSTEM AND METHOD	MyDrive Solutions Limited	European (UK)	EP2619059	Current
GG-GP486	Disc tumbler cylinder lock	Abloy OY	United Kingdom	EP2902569	Current
GG-GP485	Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity	ViiV Healthcare Company & Shionogi & Co., Ltd.	United Kingdom	EP2465580	Current
GG-GP484	Modulators of toll-like receptors	Gilead Sciences, Inc.	United Kingdom	EP2364314	Current
GG-GP483	Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors	Wyeth Holdings LLC	United Kingdom	EP2253620	Current
GG-GP482	Aminoheteroaryl compounds as protein kinase inhibitors	Sugen, Inc.	United Kingdom	EP1603570	Current
GG-GP481	Crystals including a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indole-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, processes for its preparation and compositions thereof	Pharmacia & Upjohn Company LLC	United Kingdom	EP1419151	Current
GG-GP480	Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent	Pfizer Products Inc.	United Kingdom	EP1945186	Current
GG-GP479	Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same	Wyeth LLC	United Kingdom	EP1902029	Current
GG-GP478	Nucleoside phosphoramidate prodrugs	Gilead Pharmasset LLC	United Kingdom	EP2203462	Current
GG-GP477	3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors	Incyte Corporation	United Kingdom	EP1696919	Current
GG-GP476	Magnetic tunnel junction (mtj) and method for forming the same	Qualcomm Incorporated	United Kingdom	EP2419933	Current
GG-GP475	Magnetic random access memory (mram) layout with uniform pattern	Qualcomm Incorporated	United Kingdom	EP2625689	Current
GG-GP474	On-chip low voltage capacitor-less low dropout regulator with q-control	Qualcomm Incorporated	United Kingdom	EP2564284	Current
GG-GP473	Semi-persistent scheduling grants in heterogeneous networks	Qualcomm Incorporated	United Kingdom	EP2561713	Current
GG-GP472	Adaptive resource negotiation between base stations for enhanced interference coordination	Qualcomm Incorporated	United Kingdom	EP2559291	Current
GG-GP471	Cqi estimation in a wireless communication network	Qualcomm Incorporated	United Kingdom	EP2559182	Current
GG-GP470	Feedback of control information for multiple carriers	Qualcomm Incorporated	United Kingdom	EP2556618	Current
GG-GP469	System and method to read and write data at a magnetic tunnel junction element	Qualcomm Incorporated	United Kingdom	EP2382633	Current
GG-GP468	Word line voltage control in stt-mram	Qualcomm Incorporated	United Kingdom	EP2353164	Current
GG-GP467	Low output skew double data rate serial encoder	Qualcomm Incorporated	United Kingdom	EP2055008	Current
GG-GP466	Code division multiplexing in a single-carrier frequency division multiple access system	Qualcomm Incorporated	United Kingdom	EP1922830	Current
GG-GP465	Transmit spatial diversity for cellular single frequency networks	Qualcomm Incorporated	United Kingdom	EP1894317	Current
GG-GP464	Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity	Viiv Healthcare Company & Shionogi & Co, Ltd	United Kingdom	EP1874117	Current
GG-GP463	2-(2,4,5-substituted-anilino) pyrimidine derivatives as egfr modulators useful for treating cancer	ASTRAZENECA AB	United Kingdom	EP2736895	Current
GG-GP462	Animal identification system and related method	Chamberlain, Chamberlain & Smith	United States of America	US9,007,218 B2	Current
GG-GP461	Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use	MERCK SHARP & DOHME CORP	United Kingdom	EP2485736	Current
GG-GP460	Inhibitors of hepatitis c virus replication	MERCK SHARP & DOHME CORP.	United Kingdom	EP2410844	Current
GG-GP459	Certain triazolopyrazines, compositions thereof and methods of use therefor	Hutchison Medipharma Limited	United Kingdom	EP2719699	Current
GG-GP458	Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof	CYDEX PHARMACEUTICALS, INC.	United Kingdom	EP2581078	Current
GG-GP457	Tigecycline compositions and methods of preparation	WYETH LLC	United Kingdom	EP1858488	Current
GG-GP456	Echinocandin pharmaceutical formulations containing micelle-forming surfactants	ELI LILLY & COMPANY	United KIngdom	EP1582204	Current
GG-GP455	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use	GILEAD SCIENCES, INC	United Kingdom	EP2822954	Current
GG-GP454	3-((3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor	PFIZER PRODUCTS INC.	United Kingdom	EP1666481	Current
GG-GP453	Micronized CaCO3 slurry injection system for the remineralization of desalinated and fresh water	Omya International AG	United Kingdom	EP2548848	Current
GG-GP452	Inhalation composition containing aclidinium for treatment of chronic obstructive pulmonary disease	ALMIRALL S.A.	United Kingdom	EP2265257	Current
GG- GP451	Dibenzothiazepine derivative and use thereof	ASTRAZENECA AB	The European Patent Office	EP2307389	Current
GG-GP450	Intrauterine deposit	MERCK SHARP & DOHME B.V.	European (UK)	EP2211794	Current
GG-GP449	Non-nucleoside reverse transcriptase inhibitors	MERCK CANADA INC.	United Kingdom	2552902	Current
GG- GP448	Combinations comprising antimuscarinic agents and beta-adrenergic agonists	ALMIRALL S.A.	United Kingdom	2774623	Current
GG- GP447	Vaccine comprising an oil in water emulsion adjuvant	GLAXOSMITHKLINE BIOLOGICALS S.A.	United Kingdom	EP2086582	Current
GG- GP446	Chromenone derivatives with anti -tumour activity	ASTRAZENECA AB	United Kingdom	2493870	Current
GG-GP445	Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842	ASTRAZENECA AB	United Kingdom	EP2167502	Current
GG- GP444	Pyrazinone derivatives and their use in the treatment of lung diseases	ASTRAZENECA AB	United Kingdom	EP2170848	Current
GG- GP443	Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy	ASTRAZENECA AB	United Kingdom	EP1824855	Current
GG- GP442	Modulators of pharmacokinetic properties of therapeutics	GILEAD SCIENCES, INC.	United Kingdom	EP2049506	Current
GG- GP441	Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same	GILEAD SCIENCES, INC.	United Kingdom	EP1301519	Current
GG- GP440	SUBSTITUTED CINNOLINE DERIVATIVES AS GABAA-RECEPTOR MODULATORS AND METHOD FOR THEIR SYNTHESIS	ASTRAZENECA AB	The European Office	EP1966158	Current
GG- GP439	Morpholino pyrimidines and their use in therapy	ASTRAZENECA AB	United Kingdom	EP2579877	Current
GG- GP438	Substituted diazepan compounds as orexin receptor antagonists	MERCK SHARP & DOHME CORP.	United Kingdom	EP2089382	Current
GG-GP437	Beta-lactamase inhibitors	MERCK SHARP & DOHME CORP.	The European Patent Office	2666774	Current
GG-GP436	Relocation in a communication system	VRINGO INFRASTRUCTURE, INC.	United Kingdom	EP1212919	Current
GG-GP435	Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors	ASTRAZENECA AB	United Kingdom	EP2201012	Current
GG-GP434	Novel hydrogen sulfate salt	[1] ARRAY BIOPHARMA, INC. [2] ASTRAZENECA AB	The European Patent Office	EP1968948	Current
GG-GP433	Composition for inhibition of cathepsin k	[1] Merk Sharp & Dohme Corp & [2] Merck Canada Inc.	United Kingdom	1855674	Current
GG-GP432	Heterocyclic compounds that are active as beta lactamase inhibitors	ASTRA ZENECA HOLDING FRANCE	United Kingdom	UK 2279737	Current
GG-GP431	1-alkoxy 1h-imidazo ring systems and methods	3M INNOVATIVE PROPERTIES COMPANY	United Kingdom	1789042	Current
GG-GP430	Humanized antibodies that recognize beta amyloid peptide	JANSSEN SCIENCES IRELAND UC and WYETH LLC	United Kingdom	EP1636268	Current
GG-GP429	Monodisperse pegylated naloxol compositions	NEKTAR THERAPEUTICS	United Kingdom	EP1694363	Current
GG-GP428	Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors	INCYTE CORPORATION	United Kingdom	1966202	Current
GG-GP427	Multivalent pneumococcal polysaccharide-protein conjugate composition	WYETH LLC	United Kingdom	1868645	Current
GG-GP426	Inhalation device for drugs in powder form	AstraZeneca AB	United Kingdom	2063940	Current
GG-GP425	Antibodies to human Programmed Death Receptor	Merck Sharp & Dohme B.V.	United Kingdom	2170959	Current
GG-GP424	Freeze-dried dosage form containing ondansetron	Glaxosmithkline Inc.	United Kingdom	2295318	Current
GG-GP423	DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES	Pfizer Inc.	United Kingdom	EP2334687	Current
GG-GP422	AMINO-HETEROCYCLIC COMPOUNDS	Pfizer Inc.	United Kingdom	EP2152712	Current
GG-GP421	PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS	ASTRAZENECA AB	The European Patent Office	EP1809624	Current
GG-GP420	Oxyntomodulin analogs	A) MERCK SHARP & DOHME CORP. B) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE C) INDIANA UNIVERSITY RESEARCH&TECHNOLOGY CORPORATION	United Kingdom	EP2398483	Current
GG-GP419	Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes	MERCK SHARP & DOHME CORP.	United Kingdom	EP2358717	Current
GG-GP418	4-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDES	WARNER-LAMBERT COMPANY LLC	United Kingdom	EP1746999	Current
GG-GP417	N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators	MERCK SHARP & DOHME B.V.	United Kingdom	EP2297118	Current
GG-GP416	Pyrido-, pyrazo- and pyrimidopyrimidine derivatives as mTOR inhibitors	KuDOS PHARMACEUTICALS LTD	United Kingdom	EP1954699	Current
GG-GP415	8a-azalides as veterinary antimicrobial agents	MERCK SHARP & DOHME CORP.	The European Patent Office	1510214	Current
GG-GP414	Anacetrapib and other cetp inhibitprs	MERCK SHARP & DOHME CORP.	The European Patent Office	1765793	Current
GG-GP413	LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION	GLAXOSMITHKLINE BIOLOGICALS S.A.	The European Patent Office	1863526	Current
GG-GP412	Tricyclic compounds and their use as glucocorticoid receptor modulators	Pfizer Products Inc.	The European Patent Office	2114970	Current
GG-GP411	STABILIZED PHARMACEUTICAL COMPOSITIONS COMPRISING FESOTERODINE	UCB PHARMA GMBH	The European Patent Office	2029134	Current
GG-GP410	New crystalline and amorphous form of a triazolo (4,5-D)pyrimidine compound	Astrazeneca AB	The European Patent Office	1493745	Current
GG-GP409	Screed comprising recycled glass waste	Ecoscreed Holdings Limited	The European Patent Office	EP 1 622847	Current
GG-GP408	A method of laying a floor covering	!OBAC Limited	The European Patent Office	EP1768527	Current
GG-GP407	3-aminocyclopentanecarboxamides as chemokine receptor modulators	Pfizer Inc	The European Patent Office	EP2370442	Current
GG-GP406	Pharmaceutical composition 271	A) Astrazeneca AB B) Array Biopharma, Inc.	The European Patent Office	EP2271321	Current
GG-GP405	Tricyclic compounds and their use as glucocorticoid receptor modulators	Pfizer Products Inc.	The European Patent Office	EP2114888	Current
GG-GP404	Therapeutic formulation for administering tolterodine with controlled release	Pfizer Health AB	The European Patent Office	EP1039882	Current
GG-GP403	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors	Pfizer Inc.	The European Patent Office	EP1784396	Current
GG-GP402	Tricyclic nitrogen containing compounds as antibacterial agents.	Glaxo Group Limited	The European Patent Office	EP2137196	Current
GG-GP401	5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS	PANMIRA PHARMACEUTICALS,LLC	The European Patent Office	1943219	Ceased
GG-GP400	Use of mammalian cytokine-related reagents	MERCK SHARP & DOHME CORP	The European Patent Office	2311869	Current
GG-GP399	(2S,3R)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3 YL) BENZOFURAN-2-CARBOXAMIDE, NOVEL SALT FORMS, AND METHODS OF USE THEREOF	TARGACEPT, INC	The European Patent Office	EP 2 182 949	Current
GG-GP398	5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activity	Pfizer Limited	The European Patent Office	EP 1 689 751	Current
GG-GP397	Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them	PFIZER ITALIA S.R.L.	United Kingdom	EP1320531	Ceased
GG-GP396	Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors	A) Merck Sharp & Dohme Corp B) MSD Italia S.R.L	The European Patent Office	EP 2 310 095	Current
GG-GP395	Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators	MERCK SHARP & DOHME CORP	The European Patent Office	EP 2 358 686	Current
GG-GP394	ACYLAMINOPYRAZOLES AS FGFR INHIBITORS	ASTRAZENECA AB	The European Patent Office	EP 2 125 748	Current
GG-GP393	Underwater power generator	Rotech Holdings Limited	The European Patent Office	EP 2 122 160	Current
GG-GP392	BICYCLIC HETEROARYL COMPOUNDS	ARIAD PHARMACEUTICALS, INC.	The European Patent Office	EP 1 973 545	Current
GG-GP391	HETEROAROMATIC QUINOLINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS	Pfizer Products Inc	The European Patent Office	EP 1 841757	Current
GG-GP390	QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS	ARRAY BIOPHARMA, INC	The European Patent Office	EP 1 660 090	Current
GG-GP389	ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS	PFIZER, INC.	The European Patent Office	EP 1 786 785	Current
GG-GP388	N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS	ARRAY BIOPHARMA, INC.	The European Patent Office	EP 1482932B1	Current
GG-GP387	PYRIDINE CARBOXAMIDES AS 11-BETA-HSD1 INHIBITORS	AstraZeneca AB	The European Patent Office	EP 2086939	Ceased
GG-GP386	AZOLE AND THIAZOLE DERIVATIVES AND THEIR USE	PULMAGEN THERAPEUTICS (SYNERGY) LIMITED	The European Patent Office	EP 1 924 570	Ceased
GG-GP385	NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES	Astra Zeneca Holding France SAS	The European Patent Office	EP 1 480 644 B1	Current
GG-GP384	PREPARATION OF PREGABALIN AND RELATED COMPOUNDS	WARNER-LAMBERT COMPANY LLC	The European Patent Office	EP 1 831 154	Current
GG-GP383	Prodrugs of 2,4-pyrimidinediamine compounds and their uses	RIGEL PHARMACEUTICALS, INC.	The European Patent Office	EP1856135	Ceased
GG-GP382	Time-based modeling	Brixx International Limited	United States Of America	6360188	Current
GG-GP381	SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE	Pharmacia Corporation	The European Patent Office	EP 1490064	Current
GG-GP380	HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS	Merck Sharp & Dohme Corp	The European Patent Office	EP 2276756	Current
GG-GP379	STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES	UCB Pharma GmbH	The European Patent Office	EP1230209	Current
GG-GP378	METHOD FOR ENZYMATIC PREPARATION OF (S) - 3 - CYANO -5 - METHYLHEXANOIC ACID	Pfizer Products Inc.	The European Patent Office	EP1745136	Current
GG-GP377	QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTS	ASTRAZENECA AB	United Kingdom	2094694	Ceased
GG-GP376	PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)DERIVATIVE USED AS PDE5 INHIBITORS	PFIZER PRODUCTS INC	The European Patent Office	EP1948661	Current
GG-GP375	5,7-DIAMINOPYRAZOLOÂ¬4,3-D PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION	a) PFIZER LIMITED b) PFIZER INC.	The European Patent Office	EP1620437	Current
GG-GP374	4 - Anilno Quinazoline Derivatives AS Antiproliferative Agents	AstraZeneca AB	The European Patent Office	EP 1 487 806	Current
GG-GP373	POWER GENERATING APPARATUS WITH WATER TURBINE WITH BI-SYMMETRIC AIRFOIL	Rotech Holdings Limited	United Kingdom	EP1886015B	Current
GG-GP372	1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO -2'-HYDROXY- 1,1'-BIPHENYL -3-CARBOXYLIC ACID	SMITHKLINE BEECHAM CORPORATION	The European Patent Office	EP1534390	Current
GG-GP371	AN ANTIBODY SPECIFIC FOR SOLUBLE BAFF FOR USE IN THE TREATMENT OF CANCER	BIOGEN IDEC MA INC	The European Patent Office	EP1415659	Ceased
GG-GP370	CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS	PFIZER LIMITED	The European Patent Office	EP1928821	Current
GG-GP369	POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS	Merck Sharp & Dohme Corp	The European Patent Office	EP1966151B1	Ceased
GG-GP367	Neuromuscular Blocking agents	THE WELLCOME FOUNDATION LIMITED	United Kingdom	GB2 260 763 B	Expired
GG-GP366	A NOVEL POLYMORPHIC CRYSTALLINE FORM OF FLUTICASONE PROPIONATE, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREOF	GLAXO GROUP LIMITED	The European Patent Office	EP 0 937 100 B1	Ceased
GG-GP365	METERED DOSE INHALER FOR SALMETEROL	SMITHKLINE BEECHAM CORPORTATION	The European Patent Office	EP 0 820 323 B1	Revoked
GG-GP364	CRYSTALLINE R-(RR)]-2(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0 848 705 B1	Revoked
GG-GP363	USE OF ACTIVITY INHIBITING DIPETIDYL PEPTIDASE IV EFFECTORS FOR LOWERING THE BLOOD GLUCOSE LEVEL IN MAMMALS	PROSIDION LIMITED	The European Patent Office	EP 0 896 538 B1	Revoked
GG-GP362	NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS [R- (R,R)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1)	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0 839 132 B1	Revoked
GG-GP361	METHOD FOR PREVENTING OR DELAYING CATHERTER-BASED REVASCULARIZATION	WARNER-LAMBERT COMPANY LLC	The European Patent Office	EP 1 117 392 B1	Revoked
GG-GP360	(R-(R,R)) - 2 - (4 - FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYL-ETHYL-3-PHENYL-4-((PHENYLAMINO)-CARBONYL)-1H-PYRROLE-1-HEPTANOIC ACID, ITS LACTONE FORM AND SALTS THEREOF	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0 409 281 B1	Revoked
GG-GP359	Modafinil composition of defined particle size	Cephalon, Inc.	United Kingdom	GB 2 293 103 B	Revoked
GG-GP358	7-(2-AMINOETHYL)-BENZOTHIAZOLONES	ASTRAZENECA AB	The European Patent Office	EP 0649418B1	Ceased
GG-GP357	1,2,5,6-Tetrahydropyridine-3-Carboxaldehyde Oxime Derivatives, process for their preparation, compositions containing them and their use as medicines	ROUSSEL-UCLAF	The European Patent Office	EP 0 239 445 B1	Ceased
GG-GP356	VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 806 943 B1	Ceased
GG-GP355	Medicaments for treating Gastrointestinal disorders	GLAXO GROUP LIMITED	United Kingdom	GB 2259647	Ceased
GG-GP354	Process for preparing aryl-piperidine Carbinols	BEECHAM GROUP PLC	The European Patent Office	EP 0 300 617 B1	Ceased
GG-GP353	INDOLE DERIVATIVES	GLAXO SpA	United Kingdom	GB2 266 091	Ceased
GG-GP352	Pharmaceutical compositions containing furan derivatives	GLAXO GROUP LIMITED	United Kingdom	GB 2 248 185 B	Ceased
GG-GP351	Attendance registration system by radio link	ALI GURYEL	The European Patent Office	EP 0 664 061 B1	Ceased
GG-GP350	Film-coated solid dosage form of anti-migraine drug	GLAXO GROUP LIMITED	United Kingdom	GB 2 254 784 B	Ceased
GG-GP349	Preparation of Clavulanic Acid	SMITHKLINE BEECHAM PLC	United Kingdom	GB 2 287 026B	Ceased
GG-GP348	Window Restricting Device	SECURISTYLE LIMITED	United Kingdom	GB 2246393 B	Ceased
GG-GP347	Recombinant 21 KD Cocoa Protein and Precursor	MARS UK LIMITED	United Kingdom	GB 2260327	Ceased
GG-GP346	47kD and 31 kD cocoa bean proteins and a 67 kD precursor therefor	MARS UK LIMITED	United Kingdom	GB 2260328	Ceased
GG-GP345	Improvements in cladding	SOLAGLAS LIMITED	United Kingdom	GB 2227270 B	Ceased
GG-GP344	Pyrazolopyrimidinones for the treatment of impotence	PFIZER LIMITED	The European Patent Office	EP 0 702 555 B1	Revoked
GG-GP343	USE OF MOMETASONE FLOURATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASES	Merck Sharp & Dohme Corp	The European Patent Office	EP 2 156 840 B1	Ceased
GG-GP342	DISC TUMBLER CYLINDER LOCK AND KEY COMBINATION	ABLOY OY	The European Patent Office	EP 2 029 839 B1	Current
GG-GP341	TRIAZOLOPYRIDINYLSULFANYL DERIVATIVES AS P38 MAP KINASE INHIBITORS	PFIZER LIMITED	The European Patent Office	EP 1 778 686 B9	Current
GG-GP340	TETRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERES THEREOF	MERCK SHARP & DOHME CORP	The European Patent Office	EP 1 599 469 B1	Ceased
GG-GP339	N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF	TARGACEPT INC	The European Patent Office	EP 1 519 939 B9	Ceased
GG-GP338	USE OF MOMETASONE FLOURATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASES	Merck Sharp & Dohme Corp	The European Patent Office	EP 1 174 138 B1	Ceased
GG-GP336	ANDROSTENONE DERIVATIVE	GLAXO WELLCOME INC.	The European Patent Office	EP 0 719 278 B1	Expired
GG-GP335	Electrode Structure	FORCE TECHNOLOGY	United Kingdom	GB 2306973	Ceased
GG-GP334	SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS	Merck Sharp & Dohme Corp	The European Patent Office	EP 1 347 987 B1	Current
GG-GP333	SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS	Merck Sharp & Dohme Corp	The European Patent Office	EP 0 877 750 B1	Ceased
GG-GP332	ANIMAL ACCESS SYSTEM	DAVID CHAMBERLAIN	United Kingdom	GB 2 381 180 B	Ceased
GG-GP331	SLIDING SASH WINDOWS	VENTROLLA LIMITED	United Kingdom	GB2276904	Ceased
GG-GP329	THF-CONTAINING SULFONADE INHIBITORS OF ASPARTYL PROTEASE	VERTEX PHARMACEUTICALS INCORPORATED	The European Patent Office	EP 0 846 110 B1	Current
GG-GP328	CARBOCYCLIC NUCLEOSIDE HEMISULFATE AND ITS USE IN TREATING VIRAL INFECTIONS	GLAXO GROUP LIMITED	United Kingdom	GB 2 340 491	Current
GG-GP327	HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS	Merck Sharp & Dohme Corp	The European Patent Office	EP 0 720 599 B1	Expired
GG-GP326	LIQUID COMPOSITION CONTAINING ONDANSETRON	GLAXOSMITHKLINE INC.	United Kingdom	GB 2295317B	Current
GG-GP325	METHOD OF TREATING ANDROGENIC ALOPECIA WITH 5-ALPHA REDUCTASTE INHIBITORS	Merck Sharp & Dohme Corp	The European Patent Office	EP 0 724 444 B1	Expired
GG-GP324	ELECTROCHEMICAL TREATMENT OF REINFORCED CONCRETE	ATRAVERDA LIMITED	The European Patent Office	EP 1 055 017 B1	Ceased
GG-GP323	Modafinil having defined particle size	Cephalon, Inc.	The European Patent Office	EP0731698 B1	Ceased
GG-GP322	SASH WINDOW PARTING BEADS	VENTROLLA LIMITED	United Kingdom	GB2314578	Ceased
GG-GP321	IMPROVEMENTS IN OR RELATING TO BEVERAGES	ROBINSONS SOFT DRINKS LIMITED	United Kingdom	GB2312606 B	Ceased
GG-GP320	IMPROVEMENTS IN OR RELATING TO BEVERAGES	ROBINSONS SOFT DRINKS LIMITED	United Kingdom	GB2298350 B	Ceased
GG-GP319	Synthesis of n-acetyl neuraminic acid derivatives	BIOTA SCIENTIFIC PTY LTD	The European Patent Office	EP 0 662 967 B1	Expired
GG-GP318	Plastics piping	HEPWORTH BUILDING PRODUCTS LIMITED	United Kingdom	GB2289108	Ceased
GG-GP317	PYRIMIDINE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORS	SHIONOGI SEIYAKU KABUSHIKI KAISHA	The European Patent Office	EP 0 521 471 B1	Current
GG-GP316	CARBAPENEMS CONTAINING A CARBOXY SUBSTITUTED PHENYL GROUP, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND USE AS ANTIBIOTICS	ASTRA ZENECA AB	The European Patent Office	EP 0 579 826 B1	Expired
GG-GP315	PRODRUGS OF THROMBIN INHIBITORS	ASTRAZENECA AB	The European Patent Office	EP 0 995 755 B1	Ceased
GG-GP314	Stable Oral CI-981 Formulation and Process of preparing same	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0680 320 B1	Ceased
GG-GP313	ELECTROCHEMICAL METHOD AND ELECTRODE	ATRAVERDA LIMITED	The European Patent Office	EP 0 883 700 B1	Ceased
GG-GP312	CRYSTALLINE N-ACETYL NEURAMINIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION	BIOTA SCIENTIFIC PTY LTD	The European Patent Office	EP 0734382 B1	Expired
GG-GP311	SLOT DRAIN	ALUMASC LIMITED	United Kingdom	GB2388144B	Ceased
GG-GP310	Detection of multiple articles	BTG INTERNATIONAL LIMITED	The European Patent Office	EP 0598624	Ceased
GG-GP309	FLUTICASONE PROPIONATE FORMULATIONS	GLAXO WELLCOME AUSTRALIA LTD	The European Patent Office	EP 0 760 649 B1	Expired
GG-GP308	MEDICAMENTS	GLAXO GROUP LIMITED	The European Patent Office	EP 0 616 523 B1	Ceased
GG-GP307	COMBINATION OF ATOVAQUONE WITH PROGUANIL FOR THE TREATMENT OF PROTOZOAL INFECTIONS	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 670 719 B1	Expired
GG-GP306	Transmission network	NORWEB PLC	United Kingdom	GB2 272 350	Ceased
GG-GP305	Transmission network and filter therefor	NORWEB PLC	United Kingdom	GB2 304 013	Ceased
GG-GP304	QUINAZOLINE DERIVATIVES	Astrazeneca AB	The European Patent Office	EP 0 823 900	Ceased
GG-GP303	N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS	ASTRAZENECA AB	The European Patent Office	EP 0 832 082 B1	Ceased
GG-GP302	NITRIC OXIDE SYNTHASE INHIBITORS	GLAXO GROUP LIMITED	The European Patent Office	EP 0 958 277 B1	Ceased
GG-GP301	AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 618 898 B1	Ceased
GG-GP300	Modafinil having defined particle size	Cephalon, Inc.	The European Patent Office	EP 0 966962 B1	Ceased
GG-GP299	Advertising Fitting	ESCALATOR ADVERTISING LIMITED	United Kingdom	GB2269150	Ceased
GG-GP298	SULFONAMIDE INHIBITORS OF HIV-ASPARTYL PROTEASE	VERTEX PHARMACEUTICALS INCORPORATED	The European Patent Office	EP 0 659 181 B1	Expired
GG-GP297	FREEZE-DRIED DOSAGE FORM CONTAINING ONDANSETRON	GLAXO WELLCOME INC.	United Kingdom	GB2295318B	Ceased
GG-GP296	CRYSTALLINE FORMS OF Et02C-CH2-(R)Cgl-Aze-Pab-OH	ASTRAZENECA AB	The European Patent Office	EP 1 107 980 B1	Ceased
GG-GP295	SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 0 658 161 B1	Ceased
GG-GP294	CORD LOCKING DEVICES AND SASH WINDOW PARTING BEADS	VENTROLLA LIMITED	United Kingdom	GB2298892	Ceased
GG-GP293	PAROXETINE HYDROCHLORIDE ANHYDRATE SUBSTANTIALLY FREE OF BOUND ORGANIC SOLVENT	SMITHKLINE BEECHAM PLC	United Kingdom	GB 2 297 550 B	Ceased
GG-GP291	ONDANSETRON FOR RECTAL ADMINISTRATION	LABORATORIES GLAXO SA	United Kingdom	GB2279008B	Ceased
GG-GP290	Substituted Pyrazolyl Benzenesulfonamides for the treatment of inflammation	G.D. SEARLE & CO	The European Patent Office	EP 0 731 795 B1	Expired
GG-GP289	SUSTAINED RELEASE TABLETS CONTAINING BUPROPION	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 656 775 B1	Ceased
GG-GP288	Magnifying Spectacles	MARJORIE ANNE MOYSE	United Kingdom	GB 2317966	Ceased
GG-GP287	Process for the preparation of N-Acetyl Neuraminic Acid Derivatives	BIOTA SCIENTIFIC PTY LTD	The European Patent Office	EP 0 705 256 B1	Expired
GG-GP286	QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS	ASTRAZENECA AB	The European Patent Office	EP 1 154 774 B1	Current
GG-GP285	PYRROLO 2,3-d] PYRIMIDINE COMPOUNDS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 087 971 B1	Ceased
GG-GP284	ISOTHIAZOLE DERIVATIVES USEFUL AS ANTICANCER AGENTS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 084 114 B1	Ceased
GG-GP283	VACCINE AGAINST HUMAN PAPILLOMAVIRUS (TYPES 18)	UNIVERSITY OF QUEENSLAND	The European Patent Office	EP 1359 156 B1	Expired
GG-GP282	TRIAZOLYL TROPANE DERICATIVES AS CCR5 MODULATORS	PFIZER LIMITED	The European Patent Office	EP 1 284 974 B1	Current
GG-GP281	TRICYCLIC INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASES	AGOURON PHARMACEUTICALS INC	The European Patent Office	EP 1 140 936 B1	Ceased
GG-GP280	ASYMMETRIC SYNTHESIS OF PREGABALIN	WARNER-LAMBERT COMPANY LLC	The European Patent Office	EP 1 250 311 B1	Ceased
GG-GP279	PYRROLO 2,3-d] PYRIMIDINE COMOUNDS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 087 970 B1	Ceased
GG-GP278	IMPROVEMENTS IN OR RELATING TO BEVERAGES	ROBISONS SOFT DRINKS LIMITED	United Kingdom	GB 2 312 606 B	Ceased
GG-GP277	IMPROVEMENTS IN OR RELATING TO BEVERAGES	ROBISONS SOFT DRINKS LIMITED	United Kingdom	GB 2 298 350 B	Ceased
GG-GP276	ADAMANTANE DERIVATIVES	ASTRAZENECA AB	The European Patent Office	EP 1 242 364 B1	Ceased
GG-GP275	INK CARTRIDGE FOR INK-JET PRINTING APPARATUS	SEIKO EPSON CORPORATION	United Kingdom	GB 2 369 801 B	Current
GG-GP274	INK TANK CATRIDGE AND CONTAINER THEREFOR	Seiko Epson Corportation	The European Patent Office	EP 0 553 535 B2	Expired
GG-GP273	INK TANK CATRIDGE AND CONTAINER THEREFOR	Seiko Epson Corportation	The European Patent Office	EP 1 013 444 B1	Expired
GG-GP272	INK SUPPLY UNIT	Seiko Epson Corporation	The European Patent Office	EP 1 016 533 B1	Current
GG-GP271	INK CATRIDGE AND RECORDING APPARATUS	Seiko Epson Corporation	United Kingdom	GB 2 395 684 B	Current
GG-GP270	INK CATRIDGE AND INK-JET RECORDING APPARATUS	Seiko Epson Corporation	The European Patent Office	EP 1 247 650 B1	Ceased
GG-GP269	NOVEL TRIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS	ASTRAZENECA AB	The European Patent Office	EP 1 135 391 B1	Current
GG-GP268	PHOSPHODIESTRERASE INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION	LILLY Icos LLC	The European Patent Office	EP 1 173 181 B1	Current
GG-GP267	INCLUSION COMPLEXES OF ARYL-HETEROCYCLIC SALTS	PFIZER INC	The European Patent Office	EP 0 900 088 B1	Current
GG-GP266	PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 235 830 B1	Current
GG-GP265	STRUCTURE AND METHOD FOR JOINING PARTS	PFIZER HEALTH AB	The European Patent Office	EP 0 965 002B1	Current
GG-GP264	ACRIDINE DERIVATIVE FOR INCREASING THE BIOAVAILABILITY OF TAXOL	GLAXO GROUP LIMITED	The European Patent Office	EP 1 009 436 B1	Ceased
GG-GP263	NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, A PROCESS FOR PREPARING THE FORMULATION AND USE THEREOF	ASTRAZENECA AB	The European Patent Office	EP 1 007 017 B1	Current
GG-GP262	NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING FORMOTEROL	ASTRAZENECA AB	The European Patent Office	EP 1 009 394 B1	Current
GG-GP261	QUINOLINE DERIVATIVES AS TACHYKININ NK3 RECEPTOR ANTAGONISTS	SMITHKLINE BEECHAM FARMACEUTICI S.p.A.	The European Patent Office	EP 0 804 419 B1	Ceased
GG-GP259	THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETIC	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 1 173 434 B1	Ceased
GG-GP258	2, 3-DIARYL-PYRAZOLO (1,5-B) PYRIDAZINES DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 032 575 B1	Ceased
GG-GP257	FORMULATION	ASTRAZENECA AB	United Kingdom	GB 2 359 254 B	Current
GG-GP256	Swallow Tablet Comprising Paracetamol	GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2)	The European Patent Office	EP 0 981 334 B1	Current
GG-GP255	Quinoline Derivatives as NK3 Antagonists	GlaxoSmithKline S.p.A	The European Patent Office	EP 0 874 827 B1	Ceased
GG-GP254	Process for the Synthesis of HIV Protease Inhibitors	GLAXO GROUP LIMITED	The European Patent Office	EP 1 066 276 B1	Ceased
GG-GP253	GAMES AND GAME APPARATUS	DEREK JOHN WEBB and HANNAH SARAH O'DONNELL in partnership as Prime Table Games UK	United Kingdom	GB 2291360 B	Ceased
GG-GP252	BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS	GlaxoSmithKline LLC	The European Patent Office	EP 1 047 694 B1	Current
GG-GP251	CHEMICAL COMPOUNDS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 098 898 B1	Current
GG-GP248	METHOD FOR REMOVING SURFACE COATINGS	FARROW SYSTEM LLIMITED	United Kingdom	GB 2 344 348	Ceased
GG-GP247	EXO-S-MECAMYLAMINE FORMULATION	UNIVERSITY OF SOUTH FLORIDA	The European Patent Office	EP 1 634 498 B1	Current
GG-GP246	TRIAZOLYL TROPANE DERICATIVES AS CCR5 MODULATORS	PFIZER LIMITED	The European Patent Office	EP 1 526 134 B1	Current
GG-GP245	1,2,3,4-TETRASUBSTITUTED INDOLE FOR THE TREATMENT OF RESPIRATORY DISEASES	ASTRAZENECA AB	The European Patent Office	EP 1 656 346 B1	Ceased
GG-GP244	PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES	ASTRAZENECA AB	The European Patent Office	EP 1 686 999 B1	Current
GG-GP243	REDUCTION OF DIZZINESS, A SIDE EFFECT ASSOCIATED WITH PIRFENIDONE THERAPY	INTERMUNE, INC	The European Patent Office	EP 1 965 797 B1	Current
GG-GP242	NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES	TARGACEPT INC	The European Patent Office	EP 2 094 703 B1	Current
GG-GP241	ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF	TARGACEPT INC	The European Patent Office	EP 2 085 395 B1	Ceased
GG-GP240	IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 730 119 B1	Current
GG-GP239	TRICYCLIC THROMBIN RECEPTOR ANTAGONIST	SCHERING CORPORATION	The European Patent Office	EP 2 062 890 B1	Current
GG-GP238	USE OF R- (+) -2-(3-DIISOPROYLAMINO-1-PHENYLPROPYL) -4-HYDROXY-METHYL-PHENYLISOBUTY RIC ACID ESTER HYDROGENFUMARATE FOR THE TREATMENT OF URINARY INCONTINENCE	UCB PHARMA GMBH	The European Patent Office	EP 1 690 536 B1	Current
GG-GP237	QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE Receptors	GLAXO GROUP LIMITED	The European Patent Office	EP 1 646 613 B1	Ceased
GG-GP235	VACCINE AGAINST ANTIGENS FROM BACTERIAE	GLAXOSMITHKLINE BOLOGICALS S.A.	The European Patent Office	EP 1 163 000 B1	Ceased
GG-GP234	6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACIDS-FLUOROMETHYL ESTER AS AN ANTI_INFLAMMATORY AGENT.	GLAXO GROUP LIMITED	The European Patent Office	EP 1 305 329 B1	Current
GG-GP233	ARYL FUSED AZAPOLYCYCLIC COMPOUNDS	PFIZER PRODUCTS INC	The European Patent Office	EP 1 044 189 B1	Current
GG-GP232	PHARAMACEUTICAL COMPOSITION CONTANING PROTON PUMP INHIBITORS	Merck Sharp & Dohme Corp	The European Patent Office	EP 0 819 004 B1	Ceased
GG-GP231	USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIALHYPERCHOLESTEROLEMIA	ASTRAZENECA AB	The European Patent Office	EP 1 339 409 B1	Current
GG-GP230	PHENETHANOLAMINE DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASES	GLAXO GROUP LIMITED	The European Patent Office	EP 1 425 001 B1	Current
GG-GP229	VACCINES AGAINST CANCERS	GLAXOSMITHKLINE BOLOGICALS S.A.	The European Patent Office	EP 1 326 638 B1	Current
GG-GP228	HCV NS3 PROTEASE INHIBITORS	Merck Sharp & Dohme Corp	The European Patent Office	EP 1 924 593 B1	Ceased
GG-GP227	Medical use of tetrahydrotriazolo[4.3-a]pyrazine	Merck Sharp & Dohme Corp	The European Patent Office	EP 1 625 847 B1	Ceased
GG-GP226	ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE	GLAXO GROUP LIMITED	The European Patent Office	EP 1 996 621 B1	Ceased
GG-GP225	THROMBOPOIETIN MIMETICS	GLAXOSMITHKLINE LLC	The European Patent Office	EP 1 294 378 B1	Current
GG-GP224	INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTIEN KINASES, AND METHODS FOR THEIR USE	AGOURON PHARMACEUTICALS, INC	The European Patent Office	EP 1 218 348 B1	Current
GG-GP223	IMIDAZOPYRIDINE SUBSTITUTED TROPANE DERIVATIVES WITH CCR5 RECEOTIR ANTAGONIST ACTIVITY FOR THE TREATMENT OF HIV AND INFLAMATION	PFIZER LIMITED	The European Patent Office	EP 1 682 545 B1	Current
GG-GP222	SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES	PFIZER PRODUCTS INC	The European Patent Office	EP 1 708 991 B1	Ceased
GG-GP221	Compositions containing pyrrolo -2,3-d pryrimidine derivatives	PFIZER PRODUCTS INC	The European Patent Office	EP 1 382 339 B1	Current
GG-GP220	PYRROLE SUBSTITUED 2-INDOLINONE PROTEIN KINASE INHIBITORS	a) PHARMACIA & UPJOHN COMPANY LLC b) Sugen, Inc.	The European Patent Office	EP 1 255 752 B1	Current
GG-GP219	SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES	PFIZER LIMITED	The European Patent Office	EP 1 708 992 B1	Ceased
GG-GP218	EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT	UNIVERSITY OF SOUTH FLORIDA	The European Patent Office	EP 1 139 743 B1	Ceased
GG-GP217	POWER GENERATOR AND TURBINE UNIT	ROTECH HOLDINGS LIMITED	The European Patent Office	EP 1 436 504 B1	Current
GG-GP216	UNDERWATER POWER GENERATOR	ROTECH HOLDINGS LIMITED	United Kingdom	GB 2447514 B	Current
GG-GP215	N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF	TARGACEPT INC	The European Patent Office	EP 1 519 939 B1	Ceased
GG-GP214	PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CENTERAL NERVOS SYSTEM DISORDERS COMPRISING A NICOTINE ANALOG AND AN ACTYLCHOLINESTERASE INHIBITOR	TARGACEPT INC	The European Patent Office	EP 1 102 588 B1	Ceased
GG-GP213	AZABICYCLIC COMPOUNDS FOR RELIEVING PAIN AND TREATING CENTRAL NERVOUS SYSTEM DISORDERS	TARGACEPT INC	The European Patent Office	EP 1 678 172 B1	Ceased
GG-GP212	3-Substituted-2 (Arylalkyl)-1-Azabicycloalka and methods of use thereof	TARGACEPT INC	The European Patent Office	EP 1 594 869 B9	Ceased
GG-GP211	ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF	TARGACEPT INC	The European Patent Office	EP 1 601 670 B1	Current
GG-GP210	Adjuvant systems and vaccines	GLAXOSMITHKLINE BIOLOGICALS S.A.	The European Patent Office	EP 1 126 876 B1	Ceased
GG-GP209	PYRAZOLE DERIVATIVES FOR TREATING HIV	PFIZER LIMITED	The European Patent Office	EP 1 377 556 B1	Current
GG-GP208	IMMUNOSTIMULATORY NUCLEIC ACIDS	UNIVERSITY OF IOWA RESEARCH FOUNDATION	The European Patent Office	EP 1 221 955	Ceased
GG-GP207	LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS	Bristol-Myers Squibb Holdings Ireland Unlimited Company	The European Patent Office	EP 1 427 415 B1	Current
GG-GP206	QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS	Axovant Sciences Ltd.	The European Patent Office	EP 1 497 266 B1	Current
GG-GP204	INFLUENZA VACCINE COMPOSITION	GLAXOSMITHKLINE BIOLOGICALS NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA GmbH & CO. KG	The European Patent Office	EP 1 407 008 B1	Ceased
GG-GP203	PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS	PFIZER ITALIA S.R.L.	The European Patent Office	EP 1 406 899 B1	Ceased
GG-GP202	NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION	TEVA PHARMACEUTICALS INTERNATIONAL GMBH	The European Patent Office	EP 1 240 142 B1	Current
GG-GP201	USE OF AN ANTAGONIST ANTIBODY TO THE INFLAMMATORY MEDIATOR ONCOSTATIN M (OSM)	GLAXO GROUP LIMITED	The European Patent Office	EP 1 071 449 B1	Ceased
GG-GP200	PYRIMIDINE-4-ONE DERIVATIVE AS LDL-PLA2 INHIBITOR	Smithkline Beecham PLC	The European Patent Office	EP 1 263 740 B1	Current
GG-GP199	INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE	WARNER-LAMBERT COMPANY LLC	The European Patent Office	EP 1 465 864 B1	Ceased
GG-GP198	(S, S)-REBOXETINE FOR TREATING CHRONIC PAIN	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 196 172 B1	Ceased
GG-GP197	HIGH DRUG LOAD TABLET	NOVARTIS AG, Incorporated in Switzerland	The European Patent Office	EP 1 501 485 B1	Ceased
GG-GP196	INHIBITORS OF TYROSINE KINASES	NOVARTIS AG, Incorporated in Switzerland	The European Patent Office	EP 1 532 138 B1	Current
GG-GP195	C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD	AstraZeneca AB	The European Patent Office	EP 1 506 211 B1	Current
GG-GP194	NEW FORMULATION	ASTRAZENECA AB	The European Patent Office	EP 1 000 079 B1	Current
GG-GP193	WINDANGETRIEBENES WASSERFAHRZEUG	SKYSAILS GMBH & CO., KG	The European Patent Office	EP 1 409 339 B1	Ceased
GG-GP192	THERAPEUTIC COMBINATIONS COMPRISING AMLODIPINE AND ATORVASTATIN	PFIZER PRODUCTS INC	The European Patent Office	EP 1 491 193 B1	Ceased
GG-GP190	CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTS	WARNER-LAMBERT COMPANY LLC	The European Patent Office	EP 1 032 555 B1	Ceased
GG-GP189	UNDERWATER DUCTED TURBINE	CLEAN CURRENT LIMITED PARTENERSHIP	The European Patent Office	EP 1 430 220B1	Ceased
GG-GP188	IMMUNOSTIMULATORY NUCLEIC ACIDS	UNIVERSITY OF IOWA RESEARCH FOUNDATION and COLEY PHARMACEUTICAL GMBH	The European Patent Office	EP 1 221 955 B9	Ceased
GG-GP187	SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO	ARENA PHARMACEUTICALS, INC.	The European Patent Office	EP 1 732 562 B1	Ceased
GG-GP186	VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) NUCLEIC ACID LIGAND COMPLEXES	GILEAD SCIENCES, INC.	The European Patent Office	EP 0 957 929 B1	Ceased
GG-GP185	ROPINIROLE-CONTAINING HYDROPHILIC/LIPHILIC POLYMERIC MATRIX DOSAGE FORMULATION	JAGOTEC AG	The European Patent Office	EP 1 272 167 B1	Ceased
GG-GP184	DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHLAXIS AND TREATMENT OF DISORDERS RELATED THERETO	ARENA PHARMACEUTICALS, INC.	The European Patent Office	EP 1 558 582 B1	Current
GG-GP183	QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS	ASTRAZENECA AB	The European Patent Office	EP 1 244 647 B1	Current
GG-GP182	THERAPEUTIC BIARYL DERIVATIVES	GLAXO GROUP LIMITED	The European Patent Office	EP 1 087 943 B1	Current
GG-GP180	Paving Block	Hanson Building Products Limited	United Kingdom	GB 2 338 969 B	Current
GG-GP179	CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO - (N+1) - ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY	PHARMACIA CORPORTATION	The European Patent Office	EP 1 115 695	Ceased
GG-GP178	(S,S) - REBOXETINE FOR TREATING FIBROMYALGIA AND OTHER SOMATOFORM DISORDERS	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 459 750	Ceased
GG-GP177	Compounds affecting glucokinase	ASTRAZENECA AB	The European Patent Office	EP 1 529 530 B1	Ceased
GG-GP176	OXIDATION PROCESS FOR PREPARING THE INTERMEDIATE 6.ALPHA.-DIFLURO-11.BETA.,17.ALPHA.-DIHYDROXY-16.ALPHA.-METHYL-ANDROST-1,4-DIEN-3-ONE17.BETA.-CARBOXYLIC ACID	GLAXO GROUP LIMITED	The European Patent Office	EP 1 301 526B1	Ceased
GG-GP175	(S,S) - REBOXETINE FOR TREATING FIBROMYALGIA AND OTHER SOMATOFORM DISORDERS	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 459 750 B1	Ceased
GG-GP174	THROMBOPOIETIN MIMETICS	SMITHKLINE BEECHAM CORPORTATION	The European Patent Office	EP 1 294 378 B1	Ceased
GG-GP173	(R)-CHIRAL HALOGENATED 1- SUBSTITUTEDAMINO-(N+1)- ALKANOLS USEFUL FOR INHIBITING COLESTERYL ESTER TRANSFER PROTEIN ACTIVITY	MONSATNO COMPANY	The European Patent Office	EP 1 115 695 B1	Ceased
GG-GP172	AMIDINO COMPOUND AND SALTS THEREOF USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS	PHARMACIA CORPORTATION	The European Patent Office	EP 1 265 860 B1	Ceased
GG-GP171	RECONSTITUTABLE PARENERAL COMPOSITION CONTAINING A COX-2 INHIBITOR	PHARMACIA CORPORTATION	The European Patent Office	EP 1 372 645 B1	Current
GG-GP170	PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTS	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 1 289 955 B1	Ceased
GG-GP169	CHEMICAL COMPOUNDS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 366 033 B1	Ceased
GG-GP168	PHTHALAZINONE DERIVATIVES	kuDOS Pharmaceuticals Limited	United Kingdom	GB 2 415 430 B	Current
GG-GP167	CRYSTALLINE DERIVATIVES OF 2- (5-CHLOROTHIEN-2-YL) -N- ((3S)-1((1S)-METHYL-2-MORPHOLIN-4-YL)-2-OXOETHYL)-2-OXOPYRROLINDIN-YL) ETHENSULFONAMIDE	GLAXO GROUP LIMITED	The European Patent Office	EP 1 567 519 B1	Ceased
GG-GP166	PROCESS FOR PREPARATION OF PYRAZOLO- (4,3-d) PYRIMIDIN-7-ONES AND INTERMEDIATES THEREOF	PFIZER LIMITED	The European Patent Office	EP 0 994115 B1	Ceased
GG-GP165	PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HYPERPLASIA AND OTHER DISEASES	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 203 770 B1	Expired
GG-GP164	STABLE SALTS OF NOVEL DERIVATIVES OF 3, 3-DIPHENYLPROPYLAMINES	SCHWARZ PHARAMA AG	The European Patent Office	EP 1 230 209 B1	Ceased
GG-GP163	THERAPUTIC COMBINATIONS COMPRISING AMLODIPIN AND ATORVASTATIN	PFIZER PRODUCTS INC	The European Patent Office	EP 1 003 503 B1	Ceased
GG-GP162	NEW AMINOPROPYLPHOSPHINIC ACIDS	ASTRAZENECA AB	The European Patent Office	EP 1 240 172 B1	Ceased
GG-GP161	PIPERAXINE COMPOUNDS AS TACHYKININS ANTAGONISTS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 218 359 B1	Current
GG-GP160	PYRAZOLO [4,3-D]PYRIMIDINE DERIVATIVES	PFIZER LIMITED	The European Patent Office	EP 1 220 856 B1	Ceased
GG-GP159	5HT2C RECEPTOR MODULATORS	ARENA PHARMACEUTICALS, INC.	The European Patent Office	EP 1 411 881 B9	Current
GG-GP158	PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 395 553 B1	Ceased
GG-GP157	HIV PROTEASE INHIBITORS	AGOURON PHARMACEUTICALS INC	The European Patent Office	EP 0 889 036 B1	Expired
GG-GP156	Inkjet recording apparatus and inkjet cartridge	SEIKO EPSON CORPORATION	United Kingdom	GB 2 406 544 B	Ceased
GG-GP155	ink cartridge for in jet recording apparatus	SEIKO EPSON CORPORATION	The European Patent Office	EP 0 715 958 B1	Expired
GG-GP154	ink cartridge for in jet recording apparatus	SEIKO EPSON CORPORATION	The European Patent Office	EP 0 516 088 B1	Expired
GG-GP153	A printing apparatus and ink cartridge therefore	SEIKO EPSON CORPORATION	United Kingdom	GB 2 411 863 B	Current
GG-GP152	Ink cartridge and ink cartridge holder	SEIKO EPSON CORPORATION	United Kingdom	GB 2 387 567 B	Current
GG-GP151	A printing apparatus and ink cartridge therefore	SEIKO EPSON CORPORATION	United Kingdom	GB 2 387 353 B	Current
GG-GP150	PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALS	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 1 028 961 B1	Current
GG-GP149	CHEMICAL COMPOUNDS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 326 832 B1	Ceased
GG-GP148	PROCESS FOR THE PREPARATION OF 3-OXO-4-AZASTEROIDS	GLAXO GROUP LIMITED	The European Patent Office	EP 1 335 930 B1	Ceased
GG-GP147	NOVEL METHOD OF TREATMENT	SMITHKLINE BEECHAM CORPORATION	The European Patent Office	EP 1 135 128 B1	Ceased
GG-GP146	ADJUVANT COMPOSITION COMPRISING SAPONIN AND AN IMMUNOSTIMULATORY OLIGONCLEOTIDE	GLAXOSMITHKLINE BIOLOGIVALS S.A.	The European Patent Office	EP 1 187 629 B1	Ceased
GG-GP145	NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINE	SCHWARZ PHARMA AG	The European Patent Office	EP 1 077 912 B1	Current
GG-GP144	PRINTER AND INK CARTRIDGE ATTACHED THERETO	SEIKO EPSON CORPORATION	The European Patent Office	EP 1 004 450 B1	Current
GG-GP143	INK CATRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID INJECTION APPARAUS, AND LIQUID CONTAINER	SEIKO EPSON CORPORATION	United Kingdom	GB 2 414 965 B	Ceased
GG-GP142	INK CATRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID INJECTION APPARAUS, AND LIQUID CONTAINER	SEIKO EPSON CORPORATION	United Kingdom	GB 2 409 435 B	Ceased
GG-GP141	Inkjet recording apparatus and inkjet cartridge	SEIKO EPSON CORPORATION	United Kingdom	GB 2 391 200 B	Current
GG-GP140	INK CARTRIDGE AND PRINTER USING THE SAME	SEIKO EPSON CORPORATION	United Kingdom	GB 2 347 649 B	Current
GG-GP139	ANTIVIRAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS	GLAXO GROUP LIMITED	The European Patent Office	EP0 513 917 B1	Expired
GG-GP138	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB 2157686 B	Ceased
GG-GP137	PHARMACEUTICAL COMPOSITIONS CONTAINING 1-HYDROXYPYRID-2-ONE DERIVATIVES	NATIONAL RESEARCH DEVELOPMENT CORPORATION	The European Patent Office	EP 0 138 420 B1	Ceased
GG-GP136	OPTICAL TRANSMISSION SYSTEMS	THE PLESSEY COMPANY LIMITED	United Kingdom	GB 2086168 B	Ceased
GG-GP135	PCM COMMUNICATION SYSTEM	GEC PLESSEY TELECOMMUNICATIONS LTD	United Kingdom	GB2221125 B	Ceased
GG-GP134	DATA PATH PROTECTION	GEC PLESSEY TELECOMMUNICATIONS LTD	United Kingdom	GB2220329 B	Expired
GG-GP133	PCM COMMUNICATION SYSTEM	GEC PLESSEY TELECOMMUNICATIONS LTD	United Kingdom	GB2229610 B	Expired
GG-GP132	OPTICAL TRANSMISSION APPARATUS	GEC PLESSEY TELECOMMUNICATIONS LTD	United Kingdom	GB2233851 B	Expired
GG-GP131	HETEROCYCLIC DERIVATIVES	GLAXO GROUP LIMITED	United Kingdom	GB 2 220 937	Expired
GG-GP130	ASSEMBLIES OF ELECTRICAL OR ELECTRONIC APPARATUS.	THE GENERAL ELECTRIC COMPANY P L C	United Kingdom	GB 2100522	Ceased
GG-GP129	ASSEMBLIES OF ELECTRICAL OR ELECTRONIC APPARATUS	THE GENERAL ELECTRIC COMPANY P L C	United Kingdom	GB2100118	Ceased
GG-GP128	DATA PROCESSING ARRANGEMENTS	THE GENERAL ELECTRIC COMPANY P L C	United Kingdom	GB 2099619	Ceased
GG-GP127	Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments	GLAXO GROUP LIMITED	The European Patent Office	EP 0 226 266 B1	Expired
GG-GP125	TRANSMISSIONS SYSTEMS	THE GENERAL ELECTRIC COMPANY P L C	United Kingdom	GB2145608 B	Expired
GG-GP124	Derivative of a n-phenylpyrazole	RHONE-POULENC AGRICULTURE LIMITED	The European Patent Office	EP 0295117	Expired
GG-GP123	INDOLE DERIVATIVES	GLAXO GROUP LIMITED	United Kingdom	GB 2 208 646	Expired
GG-GP122	NEW METHOD OF TRAFFIC CONTROL AND THE ROAD CONSTRUCTION ON THE CROSS SECTION OF A ROAD	YANG YIN-LUNG	United Kingdom	GB2202562	Ceased
GG-GP121	ANTIBIOTIC M 139,603 FROM STREPTOMYCES LONGISPOROFLAVUS	IMPERIAL CHEMICAL INDUSTRIES PLC	United Kingdom	GB 2027013	Ceased
GG-GP120	MEDICAMENTS	GLAXO GROUP LIMITED	United Kingdom	GB 2216414	Expired
GG-GP119	DRUG ABSORBATES	GLAXO GROUP LIMITED	United Kingdom	GB 2218333 B	Ceased
GG-GP118	PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIR	NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.	The European Patent Office	EP 0 511 991 B1	Expired
GG-GP117	THERAPEUTIC NUCLEOSIDES	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 434 450 B1	Expired
GG-GP116	PHARMACOLOGICALLY ACTIVE CNS COMPOUNDS	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 372 934 B1	Expired
GG-GP113	ELECTRICALLY-PROPELLED VEHICLE WITH INDIVIDUAL WHEEL DRIVE	ZF FRIEDRICHSHAFEN AKTIENGESELLSCHAFT	The European Patent Office	EP 1 511 646	Ceased
GG-GP112	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB 2136807B	Expired
GG-GP111	Therapeutic heterocyclic compounds	ZENECA LIMITED	The European Patent Office	EP 0 486 666 B1	Expired
GG-GP110	MOTORIC DEVICE FOR DIGGING TRENCHES IN THE SOIL WITH THE AID OF ROTARY CUTTERS	SOLETANCHE SOCIÃ‰TÃ‰ ANONYME DITE	The European Patent Office	EP 0 253 726	Ceased
GG-GP109	Derivatives and analogues of 2-Deoxy-2, 3-Didehydro-N-Acetyl Neuraminic Acid and their use as Antiviral Agents	BIOTA SCIENTIFIC MANAGEMENT PTY LTD	The European Patent Office	EP 0 526 543 B1	Expired
GG-GP108	METERING DEVICES AND MAGNETIC CARDS FOR USE WITH SUCH DEVICES	GEC TRAFFIC AUTOMATION LIMITED	United Kingdom	GB2157869	Expired
GG-GP107	MAGNETIC CARD READING DEVICES AND CARDS FOR USE WITH SUCH DEVICES	GEC TRAFFIC AUTOMATION LIMITED	United Kingdom	GB2157868	Expired
GG-GP106	PUMP FOR A DIGGING DEVICE USED FOR DIGGING TRENCHES INTO THE GROUND	SOLETANCHE SOCIÃ‰TÃ‰ ANONYME DITE	The European Patent Office	EP 0 249 555	Ceased
GG-GP103	BENZENEDIMETHANOL SUITABLE FOR MICRONISATION	GLAXO GROUP LIMITED	The European Patent Office	EP 0 639 176 B1	Expired
GG-GP102	CEPHALOSPORIN ANTIBIOTICS	GLAXO GROUP LIMITED	United Kingdom	GB 2152504 B	Ceased
GG-GP101	PHARMACEUTICAL COMPOSITION	GLAXO GROUP LIMITED	United Kingdom	GB 2 204 792 B	Expired
GG-GP98	DICHLOROANILINE DERIVATIVES	GLAXO GROUP LIMITED	United Kingdom	GB 2187734 B	Ceased
GG-GP97	PHARMACEUTICAL COMPOSITIONS	GLAXO CANADA INC	United Kingdom	GB 2 229 094 B	Expired
GG-GP96	IMPROVEMENTS RELATING TO SMOKING ARTICLES	BRITISH-AMERICAN TOBACCO COMPANY LIMITED	United Kingdom	GB 2 209 268B	Expired
GG-GP95	IMPROVEMENTS RELATING TO SMOKING ARTICLES	BRITISH-AMERICAN TOBACCO COMPANY LIMITED	United Kingdom	GB 2 209 269 B	Expired
GG-GP94	CHEMICAL COMPOUNDS	GLAXO GROUP LIMITED	United Kingdom	GB 2150932	Ceased
GG-GP93	PHARMACEUTICAL FORMULATION	FISONS PLC	United Kingdom	GB 2187953	Ceased
GG-GP92	TRANS-6-[2-(3 OR 4 - CARBOXAMIDO-SUBSTITUTED PYRROL-1-YL)-ALKYL]-4-HYDROXYPYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0247633	Expired
GG-GP79	Therapeutic heterocyclic compounds	ASTRA ZENECA AB	The European Patent Office	EP0486666	Expired
GG-GP78	HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION	GLAXO SPA	United Kingdom	GB 2181127 B	Ceased
GG-GP77	HIGH TOUGHNESS CERAMICS AND PROCESS FOR THE PREPARATION THEREOF	HITACHI, LTD	The European Patent Office	EP 0 188 129 B1	Ceased
GG-GP76	Water-Dispersible Tablets	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 522 128 B1	Expired
GG-GP75	Water-Dispersible Tablet containing Lamotrigine	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 685 231 B1	Expired
GG-GP74	PHARMACEUTICAL COMPOSITIONS	LABORATOIRES GLAXO S.A	United Kingdom	GB2219940	Expired
GG-GP72	HETEROCYCLIC AMINO COMPOUNDS	GLAXO GROUP LIMITED	The European Patent Office	EP 0 162 593	Ceased
GG-GP71	FUNGICIDAL COMPOSITION BASED ON ALUMINIUM TRIS-(ETHYL PHOSPHONATE)	RHONE-POULENC AGROCHIMIE	United Kingdom	GB 2137498B	Ceased
GG-GP70	TELECOMMUNICATIONS DIGITAL SWITCHBLOCK	THE PLESSEY COMPANY	Unknown Jurisdiction	2125254	Ceased
GG-GP69	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB2157686B	Ceased
GG-GP68	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB2146989B	Ceased
GG-GP67	ELECTRONIC DETECTION CIRCUIT	THE PLESSEY COMPANY LIMITED	United Kingdom	GB 2072461B	Ceased
GG-GP66	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB 2146989B	Expired
GG-GP65	Therapeutic nucleosides	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP0 349 242 B1	Expired
GG-GP64	MAGNETIC CARD READING DEVICES AND CARDS FOR USE WITH SUCH DEVICES	GEC TRAFFIC AUTOMATION LIMITED	United Kingdom	GB 2157868	Expired
GG-GP63	METERING DEVICES AND MAGNETIC CARDS FOR USE WITH SUCH DEVICES	GEC TRAFFIC AUTOMATION LIMITED	United Kingdom	GB 2157869	Expired
GG-GP62	HETEROCYCLIC AMINO COMPOUNDS	GLAXO GROUP LIMITED	United Kingdom	GB 2157691B	Expired
GG-GP61	LACTAM DERIVATIVES	GLAXO GROUP LIMITED	United Kingdom	GB 2209335 B	Expired
GG-GP60	AMINOCYCLOPENTANOL ACIDS AND ESTERS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION	GLAXO GROUP LIMITED	United Kingdom	GB 2097397	Ceased
GG-GP59	IMPROVEMENTS IN OR RELATING TO METHODS AND APPARATUS FOR THE CONTINUOUS FORMATION OF AN EXTRUDED PRODUCT	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB 2237237B	Ceased
GG-GP58	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	Unknown Jurisdiction	GB 2136806B	Ceased
GG-GP56	PROCESS FOR THE STABILISATION OF A SOLID PHARMACEUTICAL COMPOSITION COMPRISING CYCLIC AMINO ACIDS	GODECKE AKTIENGESELLSCHAFT	The European Patent Office	EP 0 414 263 B1	Expired
GG-GP55	New oxime derivatives of 7-amino-thiazolylacetamido-cephalosporanic acid, process for preparing them and pharmaceutical compositions incorporating them	ROUSSEL-UCLAF	United Kingdom	GB 1 580 621	Expired
GG-GP54	Crystalline form of the sodium salt of an oxyimino derivative of the 7-aminothiazolylacetamido-cephalosporanic acid, process for its preparation and pharmaceutical compositions containing it	ROUSSEL-UCLAF	The European Patent Office	EP 0 001 024 B1	Expired
GG-GP53	MEDICAMENTS	GLAXO GROUP LIMITED	United Kingdom	GB2235627 B	Revoked
GG-GP52	PIPERIDINYLCYCLOPENTANOL HEPTENOIC ACID SALT	GLAXO GROUP LIMITED	United Kingdom	GB2127406	Ceased
GG-GP51	PROCESS AND APPARATUS FOR PRODUCING GLAZED CERAMIC TILES, AND TILES SO OBTAINED	CERAMICA FILIPPO MARAZZI SPA	United Kingdom	GB 2,171,402B	Ceased
GG-GP50	PHARMACEUTICAL COMPOUNDS	ELI LILLY AND COMPANY LIMITED	The European Patent Office	EP 0 454 436 B1	Expired
GG-GP49	HETEROCYCLIC DERIVATIVES	GLAXO SPA	United Kingdom	GB2164336B	Expired
GG-GP48	AN IMPROVED PROCESS FOR THE PREPARATION OF SUBSTITUTED INDOLONE DERIVATIVES	SMITH KLINE & FRENCH LABORATORIES LIMITED	The European Patent Office	EP 0 526 529 B1	Expired
GG-GP47	New herbicidal nicotinamide derivatives	RHONE-POULENC AGRICULTURE LIMITED	The European Patent Office	EP 0053011	Expired
GG-GP46	SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES	BEECHAM GROUP PLC	The European Patent Office	EP 0 306 228 B1	Expired
GG-GP45	LACTAM DERIVATIVES	GLAXO GROUP LIMITED	United Kingdom	GB 2209335 C	Expired
GG-GP44	CRYSTALLINE 4-AMINO-1-HYDROXYBUTYLIDENE-1, 1-BISPHOSPHONIC ACID MONOSODIUM TRIHYDRATE, PROCESS THEREFOR AND COMPOSITIONS AND USE THEREOF	MERCK & CO. INC.	The European Patent Office	EP 0 402 152 B1	Expired
GG-GP42	PHARMACEUTICAL COMPOSITIONS	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB2136806	Expired
GG-GP41	3-HYDROXYPRYND-2AND-4-ONES	NATIONAL RESEARCH DEVELOPMENT CORPORATION	United Kingdom	GB2136807	Expired
GG-GP40	PHARMACEUTICAL COMPOSITIONS CONTAINING 1-HYDROXYPYRID-2-ONE DERIVATIVES	NATIONAL RESEARCH DEVELOPMENT CORPORATION	The European Patent Office	EP0138420	Ceased
GG-GP39	IMPROVEMENTS IN OR RELATING TO A STEROID COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT	GLAXO GROUP LIMITED	United Kingdom	GB2107715B	Expired
GG-GP38	INDIVIDUAL PARKING METER	JON LIE	Unknown Jurisdiction	GB2177836	Ceased
GG-GP37	OPTICAL FSK DEMODULATOR	THE PLESSEY COMPANY PLC	United Kingdom	GB2198904 B	Ceased
GG-GP35	PLANE HOLLOW REINFORCED CONCRETE FLOOR WITH TWO-DIMENSIONAL STRUCTURE	BREUNING, Jorgen Illner	The European Patent Office	EP 0 552 201 B1	Expired
GG-GP34	OPTICAL FIBRE STORAGE APPARATUS	GEC PLESSEY TELECOMMUNICATIONS LTD	Unknown Jurisdiction	GB2241221 B	Ceased
GG-GP33	TDM DATA TRANSMISSION SYSTEM	GEC PLESSEY TELECOMMUNICATIONS LTD	United Kingdom	GB2218598 B	Ceased
GG-GP32	IMPROVEMENTS IN OR RELATING TO ELECTRIC OSCILLATOR CIRCUIT ARRANGEMENTS	GENERAL ELECTRIC COMPANY LIMITED	United Kingdom	GB1603616	Expired
GG-GP31	Digital Data Signalling Systems & Apparatus	GENERAL ELECTRIC COMPANY LIMITED	United Kingdom	GB1489177	Expired
GG-GP30	HOUSING ARRANGEMENTS FOR ELECTRICAL/OR ELECTRONIC EQUIPMENT	THE GENERAL ELECTRIC COMPANY P L C	United Kingdom	GB2196798 B	Expired
GG-GP29	POWER SYSTEM FOR TELEPHONY SYSTEMS	GPT LIMITED	United Kingdom	GB2249239 B	Ceased
GG-GP27	FIBRE OPTIC CONNECTOR	GEC PLESSEY TELECOMMUNICATIONS LIMITED	United Kingdom	GB2233787 B	Ceased
GG-GP25	OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM	ROUSSEL-UCLAF	The European Patent Office	EP 0 033 255 B1	Expired
GG-GP24	HERBICIDAL CYCLOHEXANE-1,3-DIONE DERIVATIVES	ICI AUSTRALIA LIMITED	The European Patent Office	EP 0 080 301 B1	Expired
GG-GP22	PIPERIDINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS	ASTRAZENECA AB	The European Patent Office	EP 1 499 590 B8	Ceased
GG-GP21	NEW 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVE (1)	ASTRAZENECA AB	The European Patent Office	EP 1 084 103 B1	Ceased
GG-GP20	METHOD FOR THE PREPARATION OF ARYL ETHERS	PHARAMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 140 788 B1	Ceased
GG-GP19	(S, S)-REBOXETINE FOR TREATING MIGRAINE HEADACHES	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 459 751 B1	Ceased
GG-GP18	(S,S)-REBOXETINE FOR TREATING PERIPHERAL NEUROPATHY	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 459 748 B1	Ceased
GG-GP17	REBOXETINE FOR TREATING MIGRAINE HEADACHES	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 500 396 B1	Ceased
GG-GP16	(S, S)-REBOXETINE FOR TREATING INCONTINENCE	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 459 749 B1	Ceased
GG-GP15	REBOXETINE FOR TREATING PERIPHERAL NEUROPATHY	PHARMACIA & UPJOHN COMPANY LLC	The European Patent Office	EP 1 493 442 B1	Ceased
GG-GP14	PYRIDAZINO QUINOLINE COMPOUNDS	ASTRAZENECA AB	The European Patent Office	EP 0 724 583 B1	Ceased
GG-GP13	PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS	Agouron Pharmaceuticals INC	The European Patent Office	EP 1 224 177 B1	Ceased
GG-GP12	POLYMORPH OF 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2, 4-DIONE MALEIC ACID SALT	SMITHKLINE BEECHAM PLC AND SMITHKLINE BEECHAM (CORK) LIMITED	The European Patent Office	EP 1 173 435 B1	Ceased
GG-GP11	Triazine Compounds as Anxiolytics	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 689 440 B1	Ceased
GG-GP10	USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1, 2, 4-TRIAZINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT CERTAIN TYPES OF PAIN AND OF OEDEMA	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 626 851 B1	Ceased
GG-GP9	HYPOLIPIDAEMIC BENZOTHIAZEPINE COMPOUNDS	THE WELLCOME FOUNDATION LIMITED	The European Patent Office	EP 0 626 952 B1	Ceased
GG-GP8	1, 5-Benzodiazepine Derivatives and their use in medicine	GLAXO WELLCOME SpA	The European Patent Office	EP 0 558 104 B1	Ceased
GG-GP7	NEW FORMULATION FOR INHILATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING TERBUTALINE SULPHATE, A PROCESS FOR PREPARING THE FORMULATION AND THE USE THEREOF	ASTRAZENECA AB	The European Patent Office	EP 1 014 955 B1	Ceased
GG-GP6	BENZOTHIAZOLONE DERIVATIVES	ASTRAZENECA AB	The European Patent Office	EP 0850232 B1	Ceased
GG-GP5	MULTILAYER TABLET COMPRISING ROSIGLITAZONE	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 1 128 827 B1	Ceased
GG-GP3	MULTILAYER TABLET COMPRISING ROSIGLITAZONE	SMITHKLINE BEECHAM PLC	The European Patent Office	EP 1 128 827 B1	Ceased
GG-GP2	FORM III CRYSTALLINE [R-(R,R)] -2-(4-FLUOROPHENYL)-BETA-DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[PHENYLAMINO) CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID HEMI CALCIUM SALT (ATORVASTATIN)	WARNER-LAMBERT COMPANY	The European Patent Office	EP 0 848 704 B1	Ceased
GG-GP1	STABILISATION OF PHOSPHORIC ACID ESTERS	HOECHST AKTIENGESELLSCHAFT	United Kingdom	GB2000975	Ceased